UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT
INVESTMENT COMPANIES
Investment Company Act file number 811-22883
ARK ETF Trust
(Exact name of registrant as specified in charter)
c/o ARK Investment Management LLC
200 Central Avenue, Suite 1850
St. Petersburg, FL 33701
(Address of principal executive offices) (Zip code)
Corporation Service Company
2711 Centerville Road
Suite 400
Wilmington, DE 19808
(Name and address of agent for service)
Registrant’s telephone number, including area code: (727) 810-8160
Date of fiscal year end: July 31
Date of reporting period: July 31, 2022
Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
Item 1. Reports to Stockholders.
(a) | The Report to Shareholders is attached herewith. |
ANNUAL REPORT
| | Important Notice | | |
| | As permitted by regulations adopted by the Securities and Exchange Commission, paper copies of each Fund’s shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from the Fund or from your financial intermediary, such as a broker-dealer or bank. Instead, shareholder reports will be made available on http://ark-funds.com/investor-resources, and you will be notified by mail each time a report is posted and provided with a website link to access the report. If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive shareholder reports and other communications from the Funds electronically anytime by contacting your financial intermediary or, if you are a direct investor, by calling (727) 810-8160. You may elect to receive all future shareholder reports in paper free of charge. If you invest through a financial intermediary, you can contact your financial intermediary to request that you continue to receive paper copies of your shareholder reports. If you invest directly with a Fund, you can call (727) 810-8160 to let the Fund know you wish to continue receiving paper copies of your shareholder reports. Your election to receive shareholder reports in paper will apply to all funds held in your account if you invest through your financial intermediary or all funds held with the fund complex if you invest directly with the Funds. | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 5 | | | |
| | | | | 7 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 15 | | | |
| | | | | 16 | | | |
| Schedule of Investments | | | | | | | |
| | | | | 18 | | | |
| | | | | 21 | | | |
| | | | | 23 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 30 | | | |
| | | | | 32 | | | |
| | | | | 35 | | | |
| | | | | 37 | | | |
| | | | | 39 | | | |
| | | | | 41 | | | |
| | | | | 45 | | | |
| | | | | 53 | | | |
| | | | | 59 | | | |
| | | | | 61 | | | |
| | | | | 62 | | | |
| | | | | 64 | | | |
| | | | | 65 | | | |
| | | | | 67 | | |
Chief Investment Officer and Chief Executive Officer
ARK Investment Management LLC
| | | 1 Year | | | 3 Year | | | 5 Year | | | Since Inception (Annualized) | | ||||||||||||
ARK Genomic Revolution ETF (ARKG) | | ||||||||||||||||||||||||
Net Asset Value | | | | | -56.27% | | | | | | 3.59% | | | | | | 12.26% | | | | | | 9.23% | | |
Market Price | | | | | -56.32% | | | | | | 3.45% | | | | | | 12.17% | | | | | | 9.21% | | |
S&P 500 Index | | | | | -4.64% | | | | | | 13.36% | | | | | | 12.83% | | | | | | 11.94% | | |
MSCI World Net Index | | | | | -9.16% | | | | | | 9.58% | | | | | | 8.81% | | | | | | 8.40% | | |
| | | 1 Year | | | 3 Year | | | 5 Year | | | Since Inception (Annualized) | | ||||||||||||
ARK Autonomous Technology & Robotics ETF (ARKQ) | | ||||||||||||||||||||||||
Net Asset Value | | | | | -30.27% | | | | | | 19.96% | | | | | | 15.03% | | | | | | 15.09% | | |
Market Price | | | | | -30.38% | | | | | | 19.92% | | | | | | 14.99% | | | | | | 15.09% | | |
S&P 500 Index | | | | | -4.64% | | | | | ��� | 13.36% | | | | | | 12.83% | | | | | | 11.95% | | |
MSCI World Net Index | | | | | -9.16% | | | | | | 9.58% | | | | | | 8.81% | | | | | | 8.22% | | |
| | | 1 Year | | | 3 Year | | | 5 Year | | | Since Inception (Annualized) | | ||||||||||||
ARK Innovation ETF (ARKK) | | ||||||||||||||||||||||||
Net Asset Value | | | | | -62.04% | | | | | | -1.34% | | | | | | 10.41% | | | | | | 12.44% | | |
Market Price | | | | | -62.08% | | | | | | -1.42% | | | | | | 10.39% | | | | | | 12.45% | | |
S&P 500 Index | | | | | -4.64% | | | | | | 13.36% | | | | | | 12.83% | | | | | | 11.94% | | |
MSCI World Net Index | | | | | -9.16% | | | | | | 9.58% | | | | | | 8.81% | | | | | | 8.40% | | |
| | | 1 Year | | | 3 Year | | | 5 Year | | | Since Inception (Annualized) | | ||||||||||||
ARK Next Generation Internet ETF (ARKW) | | ||||||||||||||||||||||||
Net Asset Value | | | | | -61.95% | | | | | | 2.78% | | | | | | 12.25% | | | | | | 16.71% | | |
Market Price | | | | | -62.04% | | | | | | 2.64% | | | | | | 12.20% | | | | | | 16.70% | | |
S&P 500 Index | | | | | -4.64% | | | | | | 13.36% | | | | | | 12.83% | | | | | | 11.95% | | |
MSCI World Net Index | | | | | -9.16% | | | | | | 9.58% | | | | | | 8.81% | | | | | | 8.22% | | |
| | | 1 Year | | | 3 Year | | | 5 Year | | | Since Inception (Annualized) | | ||||||||||||
ARK Fintech Innovation ETF (ARKF) | | ||||||||||||||||||||||||
Net Asset Value | | | | | -64.66% | | | | | | -7.30% | | | | | | — | | | | | | -2.67% | | |
Market Price | | | | | -64.72% | | | | | | -7.37% | | | | | | — | | | | | | -2.71% | | |
S&P 500 Index | | | | | -4.64% | | | | | | 13.36% | | | | | | 12.83% | | | | | | 14.81% | | |
MSCI World Net Index | | | | | -9.16% | | | | | | 9.58% | | | | | | 8.81% | | | | | | 10.88% | | |
| | | 1 Year | | | 3 Year | | | 5 Year | | | Since Inception (Annualized) | | ||||||||||||
ARK Space Exploration & Innovation ETF (ARKX) | | ||||||||||||||||||||||||
Net Asset Value | | | | | -26.64% | | | | | | — | | | | | | — | | | | | | -19.64% | | |
Market Price | | | | | -26.60% | | | | | | — | | | | | | — | | | | | | -19.64% | | |
S&P 500 Index | | | | | -4.64% | | | | | | 13.36% | | | | | | 12.83% | | | | | | 4.73% | | |
MSCI World Net Index | | | | | -9.16% | | | | | | 9.58% | | | | | | 8.81% | | | | | | -0.10% | | |
| | | 1 Year | | | 3 Year | | | 5 Year | | | Since Inception (Annualized) | | ||||||||||||
ARK The 3D Printing ETF (PRNT) | | ||||||||||||||||||||||||
Net Asset Value | | | | | -39.14% | | | | | | 1.68% | | | | | | -1.33% | | | | | | 2.97% | | |
Market Price | | | | | -39.05% | | | | | | 1.37% | | | | | | -1.33% | | | | | | 2.98% | | |
S&P 500 Index | | | | | -4.64% | | | | | | 13.36% | | | | | | 12.83% | | | | | | 13.33% | | |
MSCI World Net Index | | | | | -9.16% | | | | | | 9.58% | | | | | | 8.81% | | | | | | 10.13% | | |
| | | 1 Year | | | 3 Year | | | 5 Year | | | Since Inception (Annualized) | | ||||||||||||
ARK Israel Innovative Technology ETF (IZRL) | | ||||||||||||||||||||||||
Net Asset Value | | | | | -35.79% | | | | | | -1.14% | | | | | | — | | | | | | 0.50% | | |
Market Price | | | | | -35.57% | | | | | | -1.31% | | | | | | — | | | | | | 0.49% | | |
S&P 500 Index | | | | | -4.64% | | | | | | 13.36% | | | | | | 12.83% | | | | | | 12.05% | | |
MSCI World Net Index | | | | | -9.16% | | | | | | 9.58% | | | | | | 8.81% | | | | | | 8.09% | | |
| | | Beginning Account Value 2/1/2022 | | | Ending Account Value 7/31/2022 | | | Annualized Expense Ratios for the Period | | | Expenses Paid During the Period(a) | | ||||||||||||
ARK Genomic Revolution ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 736.60 | | | | | | 0.75% | | | | | $ | 3.23 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
ARK Autonomous Technology & Robotics ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 850.70 | | | | | | 0.75% | | | | | $ | 3.44 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
ARK Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 599.20 | | | | | | 0.75% | | | | | $ | 2.97 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
ARK Next Generation Internet ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 575.30 | | | | | | 0.75% | | | | | $ | 2.93 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
ARK Fintech Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 552.10 | | | | | | 0.75% | | | | | $ | 2.89 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.08 | | | | | | 0.75% | | | | | $ | 3.76 | | |
ARK Space Exploration & Innovation ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 910.40 | | | | | | 0.70% | | | | | $ | 3.32 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.32 | | | | | | 0.70% | | | | | $ | 3.51 | | |
The 3D Printing ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 767.20 | | | | | | 0.66% | | | | | $ | 2.89 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,021.52 | | | | | | 0.66% | | | | | $ | 3.31 | | |
The ARK Israel Innovative Technology ETF | | | | | | | | | | | | | | | | | | | | | | | | | |
Actual | | | | $ | 1,000.00 | | | | | $ | 772.50 | | | | | | 0.49% | | | | | $ | 2.15 | | |
Hypothetical (5% return before expenses) | | | | $ | 1,000.00 | | | | | $ | 1,022.36 | | | | | | 0.49% | | | | | $ | 2.46 | | |
ETF (ARKG)
| ■ | | | Health Care | | | | | 91.5% | | |
| ■ | | | Information Technology | | | | | 4.9 | | |
| ■ | | | Materials | | | | | 3.2 | | |
| ■ | | | Money Market Fund | | | | | 0.4 | | |
| | | | | | | | | 100.0 | | |
& Robotics ETF (ARKQ)
| ■ | | | Industrials | | | | | 38.7% | | |
| ■ | | | Information Technolorgy | | | | | 30.2 | | |
| ■ | | | Consumer Discretionary | | | | | 21.8 | | |
| ■ | | | Communication Services | | | | | 7.9 | | |
| ■ | | | Health Care | | | | | 1.1 | | |
| ■ | | | Money Market Fund | | | | | 0.3 | | |
| | | | | | | | | 100.0 | | |
| ■ | | | Health Care | | | | | 35.4% | | |
| ■ | | | Information Technology | | | | | 32.5 | | |
| ■ | | | Consumer Discretionary | | | | | 13.1 | | |
| ■ | | | Communication Services | | | | | 10.1 | | |
| ■ | | | Financials | | | | | 5.5 | | |
| ■ | | | Materials | | | | | 2.2 | | |
| ■ | | | Industrials | | | | | 1.2 | | |
| ■ | | | Money Market Fund | | | | | 0.0(a) | | |
| | | | | | | | | 100.0 | | |
Internet ETF (ARKW)
| ■ | | | Information Technology | | | | | 42.3% | | |
| ■ | | | Consumer Discretionary | | | | | 19.2 | | |
| ■ | | | Communication Services | | | | | 17.7 | | |
| ■ | | | Financials | | | | | 14.5 | | |
| ■ | | | Health Care | | | | | 6.3 | | |
| ■ | | | Money Market Fund | | | | | 0.0(a) | | |
| | | | | | | | | 100.0 | | |
ETF (ARKF)
| ■ | | | Information Technology | | | | | 49.5% | | |
| ■ | | | Financials | | | | | 24.3 | | |
| ■ | | | Consumer Discretionary | | | | | 13.4 | | |
| ■ | | | Communication Services | | | | | 5.6 | | |
| ■ | | | Health Care | | | | | 3.5 | | |
| ■ | | | Real Estate | | | | | 3.1 | | |
| ■ | | | Money Market Fund | | | | | 0.6 | | |
| | | | | | | | | 100.0 | | |
& Innovation ETF (ARKX)
| ■ | | | Industrials | | | | | 53.3% | | |
| ■ | | | Information Technology | | | | | 26.1 | | |
| ■ | | | Communication Services | | | | | 9.7 | | |
| ■ | | | Equity Fund | | | | | 5.5 | | |
| ■ | | | Consumer Discretionary | | | | | 5.3 | | |
| ■ | | | Money Market Fund | | | | | 0.1 | | |
| | | | | | | | | 100.0 | | |
| ■ | | | Information Technology | | | | | 52.4% | | |
| ■ | | | Industrials | | | | | 28.4 | | |
| ■ | | | Health Care | | | | | 7.4 | | |
| ■ | | | Consumer Discretionary | | | | | 5.5 | | |
| ■ | | | Materials | | | | | 3.3 | | |
| ■ | | | Financial Services | | | | | 2.8 | | |
| ■ | | | Money Market Fund | | | | | 0.1 | | |
| ■ | | | Consumer Staples | | | | | 0.1 | | |
| | | | | | | | | 100.0 | | |
Technology ETF (IZRL)
| ■ | | | Information Technology | | | | | 64.2% | | |
| ■ | | | Health Care | | | | | 12.9 | | |
| ■ | | | Communication Services | | | | | 12.4 | | |
| ■ | | | Industrials | | | | | 6.5 | | |
| ■ | | | Consumer Discretionary | | | | | 4.0 | | |
| | | | | | | | | 100.0 | | |
Investments | | | Shares | | | Value | | ||||||
COMMON STOCKS – 99.7% | | ||||||||||||
Biotechnology – 56.4% | | ||||||||||||
Arcturus Therapeutics Holdings, Inc.*† | | | | | 2,268,443 | | | | | $ | 39,811,175 | | |
Beam Therapeutics, Inc.* | | | | | 2,028,004 | | | | | | 127,723,692 | | |
CareDx, Inc.*† | | | | | 4,390,146 | | | | | | 104,441,573 | | |
CRISPR Therapeutics AG (Switzerland)* | | | | | 1,741,089 | | | | | | 130,581,675 | | |
Exact Sciences Corp.* | | | | | 4,661,910 | | | | | | 210,252,141 | | |
Fate Therapeutics, Inc.* | | | | | 4,232,814 | | | | | | 129,227,811 | | |
Incyte Corp.* | | | | | 1,199,915 | | | | | | 93,209,397 | | |
Intellia Therapeutics, Inc.* | | | | | 1,763,198 | | | | | | 114,184,703 | | |
Ionis Pharmaceuticals, Inc.* | | | | | 3,860,299 | | | | | | 144,992,830 | | |
Iovance Biotherapeutics, Inc.* | | | | | 2,890,128 | | | | | | 33,669,991 | | |
Moderna, Inc.* | | | | | 170,027 | | | | | | 27,899,730 | | |
Nurix Therapeutics, Inc.* | | | | | 915,927 | | | | | | 14,618,195 | | |
Organovo Holdings, Inc.* | | | | | 192,850 | | | | | | 566,979 | | |
Recursion Pharmaceuticals, Inc., Class A* | | | | | 3,440,074 | | | | | | 29,103,026 | | |
Regeneron Pharmaceuticals, Inc.* | | | | | 54,859 | | | | | | 31,910,932 | | |
Repare Therapeutics, Inc. (Canada)*† | | | | | 2,736,630 | | | | | | 34,591,003 | | |
Senti Biosciences, Inc.* | | | | | 2,168,372 | | | | | | 6,787,004 | | |
Senti Biosciences, Inc.*(b) | | | | | 243,471 | | | | | | 647,755 | | |
Surface Oncology, Inc.*† | | | | | 6,323,533 | | | | | | 10,813,242 | | |
Twist Bioscience Corp.* | | | | | 2,605,186 | | | | | | 113,950,836 | | |
Veracyte, Inc.* | | | | | 1,843,569 | | | | | | 48,559,608 | | |
Vertex Pharmaceuticals, Inc.* | | | | | 233,047 | | | | | | 65,348,709 | | |
Verve Therapeutics, Inc.* | | | | | 2,232,863 | | | | | | 54,973,087 | | |
Total Biotechnology | | | | | 1,567,865,094 | | | ||||||
Chemicals – 3.2% | | ||||||||||||
Ginkgo Bioworks Holdings, Inc.* | | | | | 23,831,222 | | | | | | 68,157,295 | | |
Zymergen, Inc.*† | | | | | 7,778,905 | | | | | | 19,213,895 | | |
Total Chemicals | | | | | 87,371,190 | | | ||||||
Electronic Equipment, Instruments & Components – 2.9% | | ||||||||||||
908 Devices, Inc.*† | | | | | 3,570,847 | | | | | | 80,344,058 | | |
Health Care Equipment & Supplies – 2.1% | | ||||||||||||
Butterfly Network, Inc.* | | | | | 8,513,595 | | | | | | 36,949,002 | | |
Cerus Corp.* | | | | | 4,176,664 | | | | | | 22,553,986 | | |
Total Health Care Equipment & Supplies | | | | | 59,502,988 | | | ||||||
Health Care Providers & Services – 9.4% | | ||||||||||||
1Life Healthcare, Inc.* | | | | | 1,828,917 | | | | | | 30,981,854 | | |
Accolade, Inc.*† | | | | | 6,151,729 | | | | | | 56,841,976 | | |
Guardant Health, Inc.* | | | | | 563,761 | | | | | | 28,283,889 | | |
Invitae Corp.* | | | | | 5,369,358 | | | | | | 10,201,780 | | |
Signify Health, Inc., Class A* | | | | | 7,973,716 | | | | | | 136,430,281 | | |
Total Health Care Providers & Services | | | | | 262,739,780 | | | ||||||
Health Care Technology – 10.8% | | ||||||||||||
Schrodinger, Inc.*† | | | | | 3,432,098 | | | | | | 107,424,667 | | |
Teladoc Health, Inc.* | | | | | 3,767,146 | | | | | | 138,819,330 | | |
Veeva Systems, Inc., Class A* | | | | | 238,328 | | | | | | 53,285,375 | | |
Total Health Care Technology | | | | | 299,529,372 | | |
Investments | | | Shares | | | Value | | ||||||
Life Sciences Tools & Services – 11.3% | | ||||||||||||
10X Genomics, Inc., Class A* | | | | | 799,103 | | | | | $ | 32,083,986 | | |
Adaptive Biotechnologies Corp.*† | | | | | 8,641,074 | | | | | | 79,152,238 | | |
Berkeley Lights, Inc.* | | | | | 3,112,910 | | | | | | 13,976,966 | | |
Codexis, Inc.*† | | | | | 4,443,013 | | | | | | 30,479,069 | | |
Compugen Ltd. (Israel)* | | | | | 2,636,012 | | | | | | 4,243,979 | | |
Pacific Biosciences of California, Inc.*† | | | | | 12,013,661 | | | | | | 52,499,699 | | |
Personalis, Inc.*† | | | | | 5,415,838 | | | | | | 19,984,442 | | |
Quantum-Si, Inc.*† | | | | | 11,680,602 | | | | | | 37,961,956 | | |
SomaLogic, Inc.* | | | | | 8,695,220 | | | | | | 43,910,861 | | |
Total Life Sciences Tools & Services | | | | | 314,293,196 | | | ||||||
Pharmaceuticals – 1.6% | | ||||||||||||
ATAI Life Sciences NV (Germany)* | | | | | 4,534,456 | | | | | | 17,503,000 | | |
Pfizer, Inc. | | | | | 553,501 | | | | | | 27,957,336 | | |
Total Pharmaceuticals | | | | | 45,460,336 | | | ||||||
Software – 2.0% | | ||||||||||||
UiPath, Inc., Class A* | | | | | 3,085,604 | | | | | | 56,559,121 | | |
Total Common Stocks | | | | | | | | | | | | | |
(Cost $7,067,975,705) | | | | | | | | | | | 2,773,665,135 | | |
MONEY MARKET FUND – 0.4% | | ||||||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 1.83%(a) | | | | | | | | | | | | | |
(Cost $9,967,734) | | | | | 9,967,734 | | | | | | 9,967,734 | | |
Total Investments – 100.1% (Cost $7,077,943,439) | | | | | | | | | | | 2,783,632,869 | | |
Liabilities in Excess of Other Assets – (0.1)% | | | | | (3,607,145) | | | ||||||
Net Assets – 100.0% | | | | | | | | | | $ | 2,780,025,724 | | |
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 7/31/2022 | | | Value ($) at 7/31/2022 | | ||||||||||||||||||||||||
Common Stocks — 24.2% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Biotechnology — 6.8% | | ||||||||||||||||||||||||||||||||||||||||||||||||
AquaBounty Technologies, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
32,699,225 | | | | | 4,009,148 | | | | | | (16,947,272) | | | | | | (29,687,800) | | | | | | 9,926,699 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Arcturus Therapeutics Holdings, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
84,888,987 | | | | | 56,107,146 | | | | | | (67,886,484) | | | | | | 8,446,450 | | | | | | (41,744,924) | | | | | | — | | | | | | — | | | | | | 2,268,443 | | | | | | 39,811,175 | | |
CareDx, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
310,172,395 | | | | | 157,455,943 | | | | | | (141,292,075) | | | | | | (1,641,017) | | | | | | (220,253,673) | | | | | | — | | | | | | — | | | | | | 4,390,146 | | | | | | 104,441,573 | | |
Cellectis SA | | ||||||||||||||||||||||||||||||||||||||||||||||||
56,897,431 | | | | | 8,557,317 | | | | | | (37,117,817) | | | | | | (67,316,016) | | | | | | 38,979,085 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Evogene Ltd. | | ||||||||||||||||||||||||||||||||||||||||||||||||
9,030,619 | | | | | 1,370,733 | | | | | | (5,974,805) | | | | | | (1,103,073) | | | | | | (3,323,474) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Fate Therapeutics, Inc.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
357,383,678 | | | | | 187,569,734 | | | | | | (178,190,322) | | | | | | (4,338,123) | | | | | | (233,197,156) | | | | | | — | | | | | | — | | | | | | 4,232,814 | | | | | | 129,227,811 | | |
Ionis Pharmaceuticals, Inc.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
335,200,942 | | | | | 146,728,426 | | | | | | (325,753,351) | | | | | | (87,138,228) | | | | | | 75,955,041 | | | | | | — | | | | | | — | | | | | | 3,860,299 | | | | | | 144,992,830 | | |
Repare Therapeutics, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
93,387,201 | | | | | 52,361,878 | | | | | | (49,805,988) | | | | | | (4,852,726) | | | | | | (56,499,362) | | | | | | — | | | | | | — | | | | | | 2,736,630 | | | | | | 34,591,003 | | |
Surface Oncology, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
26,008,455 | | | | | 29,632,544 | | | | | | (19,457,716) | | | | | | (1,532,441) | | | | | | (23,837,600) | | | | | | — | | | | | | — | | | | | | 6,323,533 | | | | | | 10,813,242 | | |
Twist Bioscience Corp.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
303,792,362 | | | | | 117,653,886 | | | | | | (141,976,792) | | | | | | 9,526,597 | | | | | | (175,045,217) | | | | | | — | | | | | | — | | | | | | 2,605,186 | | | | | | 113,950,836 | | |
Chemicals — 0.7% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Zymergen, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
36,723,976 | | | | | 43,782,640 | | | | | | (18,785,592) | | | | | | 878,423 | | | | | | (43,385,552) | | | | | | — | | | | | | — | | | | | | 7,778,905 | | | | | | 19,213,895 | | |
Electronic Equipment, Instruments & Components — 2.9% | | ||||||||||||||||||||||||||||||||||||||||||||||||
908 Devices, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
81,883,531 | | | | | 85,898,782 | | | | | | (62,273,212) | | | | | | (390,933) | | | | | | (24,774,110) | | | | | | — | | | | | | — | | | | | | 3,570,847 | | | | | | 80,344,058 | | |
Financial Services — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Dynamics Special Purpose Corp. | | ||||||||||||||||||||||||||||||||||||||||||||||||
19,718,888 | | | | | 15,447,878 | | | | | | (29,907,929) | | | | | | (5,579,469) | | | | | | 320,632 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Health Care Providers & Services — 2.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Accolade, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
259,620,477 | | | | | 88,944,236 | | | | | | (102,484,784) | | | | | | (14,069,197) | | | | | | (175,168,756) | | | | | | — | | | | | | — | | | | | | 6,151,729 | | | | | | 56,841,976 | | |
Castle Biosciences, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
156,646,658 | | | | | 27,282,880 | | | | | | (108,453,903) | | | | | | (73,104,934) | | | | | | (2,370,701) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Signify Health, Inc.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
139,077,091 | | | | | 187,506,352 | | | | | | (115,490,111) | | | | | | (5,120,662) | | | | | | (69,542,389) | | | | | | — | | | | | | — | | | | | | 7,973,716 | | | | | | 136,430,281 | | |
Health Care Technology — 3.9% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Schrodinger, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
169,891,016 | | | | | 138,702,351 | | | | | | (109,632,033) | | | | | | (16,510,304) | | | | | | (75,026,363) | | | | | | — | | | | | | — | | | | | | 3,432,098 | | | | | | 107,424,667 | | |
Life Sciences Tools & Services — 7.9% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Adaptive Biotechnologies Corp. | | ||||||||||||||||||||||||||||||||||||||||||||||||
153,890,542 | | | | | 188,211,846 | | | | | | (105,355,447) | | | | | | (1,022,016) | | | | | | (156,572,687) | | | | | | — | | | | | | — | | | | | | 8,641,074 | | | | | | 79,152,238 | | |
Berkeley Lights, Inc.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
145,389,853 | | | | | 55,665,395 | | | | | | (42,605,054) | | | | | | (19,381,040) | | | | | | (125,092,188) | | | | | | — | | | | | | — | | | | | | 3,112,910 | | | | | | 13,976,966 | | |
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 7/31/2022 | | | Value ($) at 7/31/2022 | | ||||||||||||||||||||||||
Life Sciences Tools & Services — 7.9% (continued) | | ||||||||||||||||||||||||||||||||||||||||||||||||
Codexis, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
135,791,147 | | | | | 71,326,574 | | | | | | (149,599,335) | | | | | | 26,198,412 | | | | | | (53,237,729) | | | | | | — | | | | | | — | | | | | | 4,443,013 | | | | | | 30,479,069 | | |
Pacific Biosciences of California, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
460,481,139 | | | | | 141,956,876 | | | | | | (182,088,086) | | | | | | 111,328,451 | | | | | | (479,178,681) | | | | | | — | | | | | | — | | | | | | 12,013,661 | | | | | | 52,499,699 | | |
Personalis, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
97,468,702 | | | | | 64,254,700 | | | | | | (51,206,844) | | | | | | (3,572,137) | | | | | | (86,959,979) | | | | | | — | | | | | | — | | | | | | 5,415,838 | | | | | | 19,984,442 | | |
Quantum-Si, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
71,309,635 | | | | | 90,635,483 | | | | | | (56,445,287) | | | | | | (1,105,650) | | | | | | (66,432,225) | | | | | | — | | | | | | — | | | | | | 11,680,602 | | | | | | 37,961,956 | | |
Molecular Diagnostics — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
CM Life Sciences II, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
32,363,829 | | | | | 1,149,934 | | | | | | (1,108,561) | | | | | | (144,970) | | | | | | 5,547,068 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
$3,569,717,779 | | | | $ | 1,962,212,682 | | | | | $ | (2,119,838,800) | | | | | $ | (181,232,403) | | | | | $ | (1,980,914,241) | | | | | $ | — | | | | | $ | — | | | | | | 100,631,444 | | | | | $ | 1,212,137,717 | | |
ARK Genomic Revolution ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 2,773,017,380 | | | | | $ | 647,755 | | | | | $ | — | | | | | $ | 2,773,665,135 | | |
Money Market Fund | | | | | 9,967,734 | | | | | | — | | | | | | — | | | | | | 9,967,734 | | |
Total | | | | $ | 2,782,985,114 | | | | | $ | 647,755 | | | | | $ | — | | | | | $ | 2,783,632,869 | | |
Investments | | | Shares | | | Value | | ||||||
COMMON STOCKS – 99.7% | | ||||||||||||
Aerospace & Defense – 18.4% | | ||||||||||||
AeroVironment, Inc.* | | | | | 626,183 | | | | | $ | 54,252,495 | | |
Archer Aviation, Inc., Class A* | | | | | 7,874,850 | | | | | | 31,814,394 | | |
Elbit Systems Ltd. (Israel) | | | | | 126,102 | | | | | | 29,221,616 | | |
Kratos Defense & Security Solutions, Inc.*† | | | | | 6,696,343 | | | | | | 96,360,376 | | |
Lockheed Martin Corp. | | | | | 27,586 | | | | | | 11,415,363 | | |
Total Aerospace & Defense | | | | | | | | | | | 223,064,244 | | |
Airlines – 2.6% | | ||||||||||||
Blade Air Mobility, Inc.*† | | | | | 5,777,135 | | | | | | 32,091,985 | | |
Auto Components – 1.9% | | ||||||||||||
Magna International, Inc. (Canada) | | | | | 364,678 | | | | | | 23,288,337 | | |
Automobiles – 17.5% | | ||||||||||||
BYD Co. Ltd. (China)(a) | | | | | 353,288 | | | | | | 25,804,156 | | |
General Motors Co.* | | | | | 146,319 | | | | | | 5,305,527 | | |
Nio, Inc. (China)*(a) | | | | | 376,456 | | | | | | 7,427,477 | | |
Niu Technologies (China)*(a) | | | | | 2,389,963 | | | | | | 15,486,960 | | |
Tesla, Inc.* | | | | | 152,562 | | | | | | 136,001,395 | | |
XPeng, Inc., Class A (China)*(a) | | | | | 916,936 | | | | | | 22,400,746 | | |
Total Automobiles | | | | | | | | | | | 212,426,261 | | |
Biotechnology – 0.0%(b) | | ||||||||||||
Organovo Holdings, Inc.* | | | | | 91,146 | | | | | | 267,969 | | |
Diversified Consumer Services – 0.5% | | ||||||||||||
2U, Inc.* | | | | | 644,176 | | | | | | 6,306,483 | | |
Diversified Telecommunication – 5.9% | | ||||||||||||
Iridium Communications, Inc.* | | | | | 1,594,400 | | | | | | 71,285,624 | | |
Electronic Equipment, Instruments & Components – 9.6% | | ||||||||||||
Teledyne Technologies, Inc.* | | | | | 35,889 | | | | | | 14,046,955 | | |
Trimble, Inc.* | | | | | 1,478,944 | | | | | | 102,683,082 | | |
Total Electronic Equipment, Instruments & Components | | | | | | | | | | | 116,730,037 | | |
Health Care Equipment & Services – 1.1% | | ||||||||||||
Intuitive Surgical, Inc.* | | | | | 56,396 | | | | | | 12,980,668 | | |
Household Durables – 1.9% | | ||||||||||||
Vuzix Corp.* | | | | | 2,795,601 | | | | | | 22,840,060 | | |
Interactive Media & Services – 2.0% | | ||||||||||||
Alphabet, Inc., Class C* | | | | | 211,520 | | | | | | 24,671,693 | | |
Machinery – 15.0% | | ||||||||||||
Caterpillar, Inc. | | | | | 99,885 | | | | | | 19,802,201 | | |
Deere & Co. | | | | | 157,480 | | | | | | 54,043,986 | | |
Komatsu Ltd. (Japan)(a) | | | | | 1,837,672 | | | | | | 42,652,367 | | |
Markforged Holding Corp.*† | | | | | 9,711,229 | | | | | | 21,267,591 | | |
Proto Labs, Inc.* | | | | | 423,809 | | | | | | 20,720,022 | | |
Velo3D Inc.* | | | | | 7,055,650 | | | | | | 22,648,637 | | |
Total Machinery | | | | | | | | | | | 181,134,804 | | |
Investments | | | Shares | | | Value | | ||||||
Road & Rail – 2.7% | | ||||||||||||
TuSimple Holdings, Inc., Class A* | | | | | 3,271,467 | | | | | $ | 32,583,811 | | |
Semiconductors & Semiconductor Equipment – 3.5% | | ||||||||||||
Teradyne, Inc. | | | | | 416,641 | | | | | | 42,034,911 | | |
Software – 11.2% | | ||||||||||||
ANSYS, Inc.* | | | | | 49,611 | | | | | | 13,840,973 | | |
Materialise NV (Belgium)*(a) | | | | | 1,029,510 | | | | | | 14,454,320 | | |
Synopsys, Inc.* | | | | | 45,577 | | | | | | 16,749,547 | | |
UiPath, Inc., Class A* | | | | | 3,879,966 | | | | | | 71,119,777 | | |
Unity Software, Inc.* | | | | | 505,553 | | | | | | 18,902,627 | | |
Total Software | | | | | | | | | | | 135,067,244 | | |
Technology Hardware, Storage & Peripherals – 5.9% | | ||||||||||||
3D Systems Corp.* | | | | | 2,841,708 | | | | | | 32,509,139 | | |
Nano Dimension Ltd. (Israel)*(a) | | | | | 6,776,734 | | | | | | 22,295,455 | | |
Stratasys Ltd.* | | | | | 826,093 | | | | | | 17,009,255 | | |
Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 71,813,849 | | |
Total Common Stocks (Cost $1,941,568,643) | | | | | | | | | | | 1,208,587,980 | | |
MONEY MARKET FUND – 0.3% | | ||||||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 1.83%(c) (Cost $3,748,165) | | | | | 3,748,165 | | | | | | 3,748,165 | | |
Total Investments – 100.0% (Cost $1,945,316,808) | | | | | | | | | | | 1,212,336,145 | | |
Liabilities in Excess of Other Assets – (0.0)%(b) | | | | | (397,395) | | | ||||||
Net Assets – 100.0% | | | | | | | | | | $ | 1,211,938,750 | | |
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 7/31/2022 | | | Value ($) at 7/31/2022 | | ||||||||||||||||||||||||
Common Stocks — 12.4% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Aerospace & Defense — 8.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Archer Aviation, Inc.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
28,560,815 | | | | | 59,002,278 | | | | | | (18,836,402) | | | | | | (1,578,667) | | | | | | (35,333,630) | | | | | | — | | | | | | — | | | | | | 7,874,850 | | | | | | 31,814,394 | | |
Kratos Defense & Security Solutions, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
192,932,864 | | | | | 65,093,226 | | | | | | (67,480,363) | | | | | | (10,873,490) | | | | | | (83,311,861) | | | | | | — | | | | | | — | | | | | | 6,696,343 | | | | | | 96,360,376 | | |
Airlines — 2.6% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Blade Air Mobility, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
29,954,012 | | | | | 39,626,275 | | | | | | (21,141,171) | | | | | | 474,681 | | | | | | (16,821,812) | | | | | | — | | | | | | — | | | | | | 5,777,135 | | | | | | 32,091,985 | | |
Machinery — 1.8% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Markforged Holding Corp. | | ||||||||||||||||||||||||||||||||||||||||||||||||
28,017,642 | | | | | 83,489,274 | | | | | | (22,154,066) | | | | | | (2,170,909) | | | | | | (65,914,350) | | | | | | — | | | | | | — | | | | | | 9,711,229 | | | | | | 21,267,591 | | |
Velo3D Inc.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
26,430,752 | | | | | 53,144,681 | | | | | | (15,988,196) | | | | | | 465,542 | | | | | | (41,404,143) | | | | | | — | | | | | | — | | | | | | 7,055,650 | | | | | | 22,648,637 | | |
$305,896,085 | | | | $ | 300,355,734 | | | | | $ | (145,600,198) | | | | | $ | (13,682,843) | | | | | $ | (242,785,796) | | | | | $ | — | | | | | $ | — | | | | | | 37,115,207 | | | | | $ | 204,182,983 | | |
ARK Autonomous Technology & Robotics ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 1,208,587,980 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,208,587,980 | | |
Money Market Fund | | | | | 3,748,165 | | | | | | — | | | | | | — | | | | | | 3,748,165 | | |
Total | | | | $ | 1,212,336,145 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,212,336,145 | | |
Investments | | | Shares | | | Value | | ||||||
COMMON STOCKS – 100.0% | | ||||||||||||
Automobiles – 10.0% | | ||||||||||||
Tesla, Inc.* | | | | | 1,041,513 | | | | | $ | 928,456,764 | | |
Biotechnology – 24.8% | | ||||||||||||
Beam Therapeutics, Inc.*† | | | | | 6,753,101 | | | | | | 425,310,301 | | |
CRISPR Therapeutics AG (Switzerland)*† | | | | | 6,341,771 | | | | | | 475,632,825 | | |
Exact Sciences Corp.*† | | | | | 10,053,642 | | | | | | 453,419,254 | | |
Fate Therapeutics, Inc.*† | | | | | 7,145,093 | | | | | | 218,139,689 | | |
Intellia Therapeutics, Inc.*† | | | | | 6,652,418 | | | | | | 430,810,590 | | |
Twist Bioscience Corp.*† | | | | | 4,089,618 | | | | | | 178,879,891 | | |
Veracyte, Inc.*† | | | | | 5,216,029 | | | | | | 137,390,204 | | |
Total Biotechnology | | | | | | | | | | | 2,319,582,754 | | |
Capital Markets – 5.5% | | ||||||||||||
Coinbase Global, Inc., Class A* | | | | | 4,994,141 | | | | | | 314,431,117 | | |
Robinhood Markets, Inc., Class A* | | | | | 22,001,400 | | | | | | 199,112,670 | | |
Total Capital Markets | | | | | | | | | | | 513,543,787 | | |
Chemicals – 2.1% | | ||||||||||||
Ginkgo Bioworks Holdings, Inc.*† | | | | | 70,022,979 | | | | | | 200,265,720 | | |
Diversified Consumer Services – 0.7% | | ||||||||||||
2U, Inc.*† | | | | | 6,564,563 | | | | | | 64,267,072 | | |
Entertainment – 10.1% | | ||||||||||||
ROBLOX Corp., Class A* | | | | | 6,058,093 | | | | | | 260,073,933 | | |
Roku, Inc.*† | | | | | 9,111,942 | | | | | | 597,014,440 | | |
Spotify Technology SA* | | | | | 778,158 | | | | | | 87,947,417 | | |
Total Entertainment | | | | | | | | | | | 945,035,790 | | |
Health Care Equipment & Supplies – 0.7% | | ||||||||||||
Cerus Corp.*† | | | | | 11,914,339 | | | | | | 64,337,431 | | |
Health Care Providers & Services – 2.8% | | ||||||||||||
Invitae Corp.*† | | | | | 18,534,029 | | | | | | 35,214,655 | | |
Signify Health, Inc., Class A*† | | | | | 13,363,378 | | | | | | 228,647,398 | | |
Total Health Care Providers & Services | | | | | | | | | | | 263,862,053 | | |
Health Care Technology – 4.7% | | ||||||||||||
Teladoc Health, Inc.*† | | | | | 11,927,889 | | | | | | 439,542,710 | | |
Hotels, Restaurants & Leisure – 2.5% | | ||||||||||||
DraftKings, Inc., Class A* | | | | | 16,787,858 | | | | | | 230,497,290 | | |
IT Services – 12.1% | | ||||||||||||
Block, Inc.* | | | | | 6,281,745 | | | | | | 477,789,525 | | |
Shopify, Inc., Class A (Canada)* | | | | | 9,117,361 | | | | | | 317,557,684 | | |
Twilio, Inc., Class A* | | | | | 3,945,847 | | | | | | 334,607,825 | | |
Total IT Services | | | | | | | | | | | 1,129,955,034 | | |
Investments | | | Shares | | | Value | | ||||||
Life Sciences Tools & Services – 2.4% | | ||||||||||||
10X Genomics, Inc., Class A* | | | | | 3,298,387 | | | | | $ | 132,430,238 | | |
Berkeley Lights, Inc.*† | | | | | 4,064,643 | | | | | | 18,250,247 | | |
Compugen Ltd. (Israel)*† | | | | | 5,913,683 | | | | | | 9,521,030 | | |
Pacific Biosciences of California, Inc.*† | | | | | 14,078,988 | | | | | | 61,525,177 | | |
Total Life Sciences Tools & Services | | | | | | | | | | | 221,726,692 | | |
Road & Rail – 1.2% | | ||||||||||||
TuSimple Holdings, Inc., Class A*† | | | | | 10,787,186 | | | | | | 107,440,372 | | |
Semiconductors & Semiconductor Equipment – 1.0% | | ||||||||||||
NVIDIA Corp. | | | | | 490,096 | | | | | | 89,016,137 | | |
Software – 19.4% | | ||||||||||||
Materialise NV (Belgium)*†(a) | | | | | 4,247,609 | | | | | | 59,636,430 | | |
PagerDuty, Inc.*† | | | | | 8,319,627 | | | | | | 215,727,928 | | |
UiPath, Inc., Class A* | | | | | 22,542,083 | | | | | | 413,196,381 | | |
Unity Software, Inc.* | | | | | 8,560,447 | | | | | | 320,075,113 | | |
Zoom Video Communications, Inc., Class A* | | | | | 7,803,524 | | | | | | 810,474,003 | | |
Total Software | | | | | | | | | | | 1,819,109,855 | | |
Total Common Stocks (Cost $21,299,412,263) | | | | | | | | | | | 9,336,639,461 | | |
MONEY MARKET FUND – 0.0%(b) | | ||||||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 1.83%(c) (Cost $3,169,465) | | | | | 3,169,465 | | | | | | 3,169,465 | | |
Total Investments – 100.0% (Cost $21,302,581,728) | | | | | | | | | | | 9,339,808,926 | | |
Liabilities in Excess of Other Assets – (0.0)%(b) | | | | | (2,989,907) | | | ||||||
Net Assets – 100.0% | | | | | | | | | | $ | 9,336,819,019 | | |
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 7/31/2022 | | | Value ($) at 7/31/2022 | | ||||||||||||||||||||||||
Common Stocks — 47.3% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Biotechnology — 24.8% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Beam Therapeutics, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
429,666,220 | | | | | 676,046,277 | | | | | | (524,849,273) | | | | | | 14,774,288 | | | | | | (170,327,211) | | | | | | — | | | | | | — | | | | | | 6,753,101 | | | | | | 425,310,301 | | |
CRISPR Therapeutics AG | | ||||||||||||||||||||||||||||||||||||||||||||||||
590,141,202 | | | | | 721,847,564 | | | | | | (607,804,852) | | | | | | 62,101,963 | | | | | | (290,653,052) | | | | | | — | | | | | | — | | | | | | 6,341,771 | | | | | | 475,632,825 | | |
Editas Medicine, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
179,157,870 | | | | | 60,451,666 | | | | | | (169,471,797) | | | | | | (22,174,212) | | | | | | (47,963,527) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Exact Sciences Corp. | | ||||||||||||||||||||||||||||||||||||||||||||||||
685,472,559 | | | | | 1,027,694,317 | | | | | | (765,962,446) | | | | | | (2,261,206) | | | | | | (491,523,970) | | | | | | — | | | | | | — | | | | | | 10,053,642 | | | | | | 453,419,254 | | |
Fate Therapeutics, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
368,294,731 | | | | | 499,627,377 | | | | | | (349,543,311) | | | | | | (4,105,330) | | | | | | (296,133,778) | | | | | | — | | | | | | — | | | | | | 7,145,093 | | | | | | 218,139,689 | | |
Intellia Therapeutics, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
588,966,306 | | | | | 866,751,840 | | | | | | (646,075,201) | | | | | | 350,605,514 | | | | | | (729,437,869) | | | | | | — | | | | | | — | | | | | | 6,652,418 | | | | | | 430,810,590 | | |
Iovance Biotherapeutics, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
189,057,134 | | | | | 36,882,663 | | | | | | (203,371,000) | | | | | | (164,614,792) | | | | | | 142,045,995 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Twist Bioscience Corp. | | ||||||||||||||||||||||||||||||||||||||||||||||||
226,589,192 | | | | | 271,361,821 | | | | | | (181,514,464) | | | | | | 18,064,266 | | | | | | (155,620,924) | | | | | | — | | | | | | — | | | | | | 4,089,618 | | | | | | 178,879,891 | | |
Veracyte, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
146,417,966 | | | | | 258,969,781 | | | | | | (185,067,705) | | | | | | 24,060,275 | | | | | | (106,990,113) | | | | | | — | | | | | | — | | | | | | 5,216,029 | | | | | | 137,390,204 | | |
Chemcials — 2.1% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Ginkgo Bioworks Holdings, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
— | | | | | 632,655,332 | | | | | | (221,911,062) | | | | | | 19,926,262 | | | | | | (230,404,812) | | | | | | — | | | | | | — | | | | | | 70,022,979 | | | | | | 200,265,720 | | |
Diversified Consumer Services — 0.7% | | ||||||||||||||||||||||||||||||||||||||||||||||||
2U, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
223,797,134 | | | | | 148,393,884 | | | | | | (129,821,240) | | | | | | 15,640,578 | | | | | | (193,743,284) | | | | | | — | | | | | | — | | | | | | 6,564,563 | | | | | | 64,267,072 | | |
Diversified Telecommunication — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Iridium Communications, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
351,317,071 | | | | | 128,645,635 | | | | | | (427,230,884) | | | | | | (44,184,594) | | | | | | (8,547,228) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Entertainment — 6.4% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Roku, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
1,277,506,103 | | | | | 2,073,736,883 | | | | | | (1,143,452,929) | | | | | | 188,702,111 | | | | | | (1,799,477,728) | | | | | | — | | | | | | — | | | | | | 9,111,942 | | | | | | 597,014,440 | | |
Health Care Equipment & Supplies — 0.7% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Cerus Corp. | | ||||||||||||||||||||||||||||||||||||||||||||||||
61,502,127 | | | | | 77,679,735 | | | | | | (81,802,924) | | | | | | 3,105,813 | | | | | | 3,852,680 | | | | | | — | | | | | | — | | | | | | 11,914,339 | | | | | | 64,337,431 | | |
Health Care Providers & Services — 2.8% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Invitae Corp. | | ||||||||||||||||||||||||||||||||||||||||||||||||
331,826,516 | | | | | 408,986,992 | | | | | | (261,982,756) | | | | | | 33,660,916 | | | | | | (477,277,013) | | | | | | — | | | | | | — | | | | | | 18,534,029 | | | | | | 35,214,655 | | |
Signify Health, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
— | | | | | 496,645,082 | | | | | | (219,584,785) | | | | | | 6,807,469 | | | | | | (55,220,368) | | | | | | — | | | | | | — | | | | | | 13,363,378 | | | | | | 228,647,398 | | |
Health Care Technology — 4.7% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Teladoc Health, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
1,309,104,544 | | | | | 1,377,423,723 | | | | | | (1,088,068,284) | | | | | | (11,221,955) | | | | | | (1,147,695,318) | | | | | | — | | | | | | — | | | | | | 11,927,889 | | | | | | 439,542,710 | | |
Life Sciences Tools & Services — 1.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Berkeley Lights, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
158,277,143 | | | | | 117,143,552 | | | | | | (82,435,191) | | | | | | (63,530,302) | | | | | | (111,204,955) | | | | | | — | | | | | | — | | | | | | 4,064,643 | | | | | | 18,250,247 | | |
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 7/31/2022 | | | Value ($) at 7/31/2022 | | ||||||||||||||||||||||||
Life Sciences Tools & Services — 1.0% (continued) | | ||||||||||||||||||||||||||||||||||||||||||||||||
Compugen Ltd. | | ||||||||||||||||||||||||||||||||||||||||||||||||
43,591,664 | | | | | 25,473,574 | | | | | | (30,347,286) | | | | | | (11,029,221) | | | | | | (18,167,701) | | | | | | — | | | | | | — | | | | | | 5,913,683 | | | | | | 9,521,030 | | |
Pacific Biosciences of California, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
246,859,499 | | | | | 323,925,942 | | | | | | (202,294,174) | | | | | | 61,620,306 | | | | | | (368,586,396) | | | | | | — | | | | | | — | | | | | | 14,078,988 | | | | | | 61,525,177 | | |
Machinery — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Proto Labs, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
155,624,215 | | | | | 12,316,665 | | | | | | (150,882,022) | | | | | | (120,312,087) | | | | | | 103,253,229 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Road & Rail — 1.2% | | ||||||||||||||||||||||||||||||||||||||||||||||||
TuSimple Holdings, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
166,882,333 | | | | | 321,930,785 | | | | | | (204,369,338) | | | | | | 9,473,421 | | | | | | (186,476,829) | | | | | | — | | | | | | — | | | | | | 10,787,186 | | | | | | 107,440,372 | | |
Software — 2.9% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Materialise NV | | ||||||||||||||||||||||||||||||||||||||||||||||||
80,375,733 | | | | | 115,139,235 | | | | | | (102,529,469) | | | | | | (7,578,555) | | | | | | (25,770,514) | | | | | | — | | | | | | — | | | | | | 4,247,609 | | | | | | 59,636,430 | | |
PagerDuty, Inc. | | ||||||||||||||||||||||||||||||||||||||||||||||||
224,620,189 | | | | | 417,064,119 | | | | | | (320,555,028) | | | | | | 49,335,161 | | | | | | (154,736,513) | | | | | | — | | | | | | — | | | | | | 8,319,627 | | | | | | 215,727,928 | | |
Technology Hardware, Storage & Peripherals — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Stratasys Ltd. | | ||||||||||||||||||||||||||||||||||||||||||||||||
81,818,214 | | | | | 169,816,565 | | | | | | (239,686,218) | | | | | | (16,888,732) | | | | | | 4,940,171 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
$8,116,865,665 | | | | $ | 11,266,611,009 | | | | | $ | (8,540,613,639) | | | | | $ | 389,977,357 | | | | | $ | (6,811,867,028) | | | | | $ | — | | | | | $ | — | | | | | | 235,102,527 | | | | | $ | 4,420,973,364 | | |
ARK Innovation ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 9,336,639,461 | | | | | $ | — | | | | | $ | — | | | | | $ | 9,336,639,461 | | |
Money Market Fund | | | | | 3,169,465 | | | | | | — | | | | | | — | | | | | | 3,169,465 | | |
Total | | | | $ | 9,339,808,926 | | | | | $ | — | | | | | $ | — | | | | | $ | 9,339,808,926 | | |
Investments | | | Shares | | | Value | | ||||||
COMMON STOCKS – 94.0% | | ||||||||||||
Automobiles – 9.4% | | ||||||||||||
Tesla, Inc.* | | | | | 153,836 | | | | | $ | 137,137,102 | | |
Banks – 0.5% | | | | ||||||||||
NU Holdings Ltd., Class A (Brazil)* | | | | | 1,583,909 | | | | | | 6,668,257 | | |
Biotechnology – 1.7% | | | | ||||||||||
Veracyte, Inc.* | | | | | 946,325 | | | | | | 24,926,200 | | |
Capital Markets – 7.9% | | | | ||||||||||
Coinbase Global, Inc., Class A* | | | | | 1,269,174 | | | | | | 79,907,195 | | |
Robinhood Markets, Inc., Class A* | | | | | 3,826,117 | | | | | | 34,626,359 | | |
Total Capital Markets | | | | | | | | | | | 114,533,554 | | |
Diversified Consumer Services – 0.8% | | | | ||||||||||
2U, Inc.* | | | | | 1,158,339 | | | | | | 11,340,139 | | |
Entertainment – 16.6% | | | | ||||||||||
Endeavor Group Holdings, Inc., Class A* | | | | | 467,749 | | | | | | 10,660,000 | | |
ROBLOX Corp., Class A* | | | | | 1,551,199 | | | | | | 66,592,973 | | |
Roku, Inc.* | | | | | 1,513,810 | | | | | | 99,184,831 | | |
Sea Ltd. (Singapore)*(a) | | | | | 321,024 | | | | | | 24,500,552 | | |
Spotify Technology SA* | | | | | 361,049 | | | | | | 40,805,758 | | |
Total Entertainment | | | | | | | | | | | 241,744,114 | | |
Health Care Technology – 4.6% | | | | ||||||||||
Teladoc Health, Inc.* | | | | | 1,812,061 | | | | | | 66,774,448 | | |
Hotels, Restaurants & Leisure – 4.9% | | | | ||||||||||
DraftKings, Inc., Class A* | | | | | 4,272,184 | | | | | | 58,657,087 | | |
Genius Sports Ltd. (United Kingdom)* | | | | | 5,203,314 | | | | | | 13,476,583 | | |
Total Hotels, Restaurants & Leisure | | | | | | | | | | | 72,133,670 | | |
Household Durables – 2.3% | | | | ||||||||||
Vuzix Corp.*† | | | | | 3,981,596 | | | | | | 32,529,639 | | |
Interactive Media & Services – 1.2% | | | | ||||||||||
Nextdoor Holdings, Inc.* | | | | | 5,028,586 | | | | | | 16,845,763 | | |
Twitter, Inc.* | | | | | 241 | | | | | | 10,028 | | |
Total Interactive Media & Services | | | | | | | | | | | 16,855,791 | | |
Internet & Direct Marketing Retail – 1.8% | | ||||||||||||
MercadoLibre, Inc. (Brazil)* | | | | | 32,777 | | | | | | 26,670,973 | | |
IT Services – 19.0% | | | | ||||||||||
Adyen NV (Netherlands)*(a) | | | | | 1,141,211 | | | | | | 20,564,622 | | |
Block, Inc.* | | | | | 1,309,232 | | | | | | 99,580,186 | | |
Cloudflare, Inc., Class A* | | | | | 318,665 | | | | | | 16,035,223 | | |
Shopify, Inc., Class A (Canada)* | | | | | 2,071,725 | | | | | | 72,158,182 | | |
Twilio, Inc., Class A* | | | | | 808,468 | | | | | | 68,558,086 | | |
Total IT Services | | | | | | | | | | | 276,896,299 | | |
Semiconductors & Semiconductor Equipment – 1.3% | | ||||||||||||
NVIDIA Corp. | | | | | 102,248 | | | | | | 18,571,304 | | |
Investments | | | Shares | | | Value | | ||||||
Software – 20.7% | | | | ||||||||||
Crowdstrike Holdings, Inc., Class A* | | | | | 119,013 | | | | | $ | 21,850,787 | | |
monday.com Ltd.* | | | | | 245,855 | | | | | | 25,256,684 | | |
PagerDuty, Inc.* | | | | | 1,483,394 | | | | | | 38,464,406 | | |
UiPath, Inc., Class A* | | | | | 3,238,327 | | | | | | 59,358,534 | | |
Unity Software, Inc.* | | | | | 1,117,431 | | | | | | 41,780,745 | | |
Zoom Video Communications, Inc., Class A* | | | | | 1,109,421 | | | | | | 115,224,465 | | |
Total Software | | | | | | | | | | | 301,935,621 | | |
Technology Hardware, Storage & Peripherals – 1.3% | | ||||||||||||
Nano Dimension Ltd. (Israel)*(a) | | | | | 5,981,150 | | | | | | 19,677,983 | | |
Total Common Stocks (Cost $3,559,665,416) | | | | | | | | | | | 1,368,395,094 | | |
UNIT TRUST – 6.1% | | | | | | | | | | | | | |
Financials – 6.1% | | | | ||||||||||
Grayscale Bitcoin Trust BTC* (Cost $229,843,474) | | | | | 6,005,197 | | | | | | 88,876,916 | | |
MONEY MARKET FUND – 0.0%(b) | | | | | | | | | | | | | |
Dreyfus Government Cash Management Fund, Institutional Shares, 1.83%(c) (Cost $129,914) | | | | | 129,914 | | | | | | 129,914 | | |
Total Investments – 100.1% (Cost $3,789,638,804) | | | | | | | | | | | 1,457,401,924 | | |
Liabilities in Excess of Other Assets – (0.1)% | | | | | (902,745) | | | ||||||
Net Assets – 100.0% | | | | | | | | | | $ | 1,456,499,179 | | |
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 7/31/2022 | | | Value ($) at 7/31/2022 | | | | | | | | | | ||||||||||||||||||||||||||||||||||||||||
Common Stocks — 2.2% | | | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital Markets — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||||||
Concord Acquisition Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||||||
28,340,692 | | | | | 20,297,582 | | | | | | (47,415,233) | | | | | | (2,135,524) | | | | | | 912,483 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | | | | | | ||||||||||||||||
Household Durables — 2.2% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||||||
Vuzix Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||||||
59,763,791 | | | | | 38,747,199 | | | | | | (33,006,503) | | | | | | (8,009,875) | | | | | | (24,964,973) | | | | | | — | | | | | | — | | | | | | 3,981,596 | | | | | | 32,529,639 | | | | | | | | | | | ||||||||||||||||
Interactive Media & Services — 0.0% | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||||||||||||||||||||||||||||||||||||||
Nextdoor Holdings, Inc.^ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||||||
44,079,858 | | | | | 33,256,362 | | | | | | (26,538,105) | | | | | | (1,758,727) | | | | | | (32,193,625) | | | | | | — | | | | | | — | | | | | | 5,028,586 | | | | | | 16,845,763 | | | | | | | | | | | ||||||||||||||||
$132,184,341 | | | | $ | 92,301,143 | | | | | $ | (106,959,841) | | | | | $ | (11,904,126) | | | | | $ | (56,246,115) | | | | | $ | — | | | | | $ | — | | | | | | 9,010,182 | | | | | $ | 49,375,402 | | | | | | | | | | |
ARK Next Generation Internet ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 1,368,395,094 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,368,395,094 | | |
Unit Trust‡ | | | | | 88,876,916 | | | | | | — | | | | | | — | | | | | | 88,876,916 | | |
Money Market Fund | | | | | 129,914 | | | | | | — | | | | | | — | | | | | | 129,914 | | |
Total | | | | $ | 1,457,401,924 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,457,401,924 | | |
Investments | | | Shares | | | Value | | ||||||
COMMON STOCKS – 99.6% | | | | ||||||||||
Banks – 6.0% | | ||||||||||||
NU Holdings Ltd., Class A (Brazil)* | | | | | 3,317,768 | | | | | $ | 13,967,803 | | |
Silvergate Capital Corp., Class A* | | | | | 448,454 | | | | | | 41,836,274 | | |
TCS Group Holding PLC, Class Reg S (Russia)*(a)(b) | | | | | 607,059 | | | | | | 6,071 | | |
Total Banks | | | | | | | | | | | 55,810,148 | | |
Capital Markets – 12.6% | | | | ||||||||||
Coinbase Global, Inc., Class A* | | | | | 973,406 | | | | | | 61,285,642 | | |
Intercontinental Exchange, Inc. | | | | | 106,233 | | | | | | 10,834,704 | | |
Robinhood Markets, Inc., Class A* | | | | | 5,037,531 | | | | | | 45,589,655 | | |
Total Capital Markets | | | | | | | | | | | 117,710,001 | | |
Consumer Finance – 1.2% | | | | ||||||||||
Kaspi.KZ JSC (Kazakhstan)(a) | | | | | 211,599 | | | | | | 11,108,947 | | |
Entertainment – 3.8% | | | | ||||||||||
Roku, Inc.* | | | | | 143,185 | | | | | | 9,381,481 | | |
Sea Ltd. (Singapore)*(c) | | | | | 339,125 | | | | | | 25,882,020 | | |
Total Entertainment | | | | | | | | | | | 35,263,501 | | |
Health Care Technology – 3.5% | | | | ||||||||||
Teladoc Health, Inc.* | | | | | 887,202 | | | | | | 32,693,394 | | |
Hotels, Restaurants & Leisure – 3.8% | | | | ||||||||||
DraftKings, Inc., Class A* | | | | | 2,626,224 | | | | | | 36,058,055 | | |
Insurance – 4.6% | | | | ||||||||||
Discovery Ltd. (South Africa)* | | | | | 5,632,323 | | | | | | 43,475,976 | | |
Interactive Media & Services – 1.8% | | | | ||||||||||
Twitter, Inc.* | | | | | 1,510 | | | | | | 62,831 | | |
Z Holdings Corp. (Japan) | | | | | 4,837,114 | | | | | | 17,016,049 | | |
Total Interactive Media & Services | | | | | | | | | | | 17,078,880 | | |
Internet & Direct Marketing Retail – 9.6% | | | | ||||||||||
Farfetch Ltd., Class A (United Kingdom)* | | | | | 736,211 | | | | | | 5,845,516 | | |
Global-e Online Ltd. (Israel)* | | | | | 1,061,462 | | | | | | 24,158,875 | | |
JD.com, Inc. (China)(c) | | | | | 177,716 | | | | | | 10,574,102 | | |
MercadoLibre, Inc. (Brazil)* | | | | | 61,110 | | | | | | 49,725,818 | | |
Total Internet & Direct Marketing Retail | | | | | | | | | | | 90,304,311 | | |
IT Services – 38.0% | | | | ||||||||||
Adyen NV (Netherlands)*(d) | | | | | 25,343 | | | | | | 45,198,466 | | |
Block, Inc.* | | | | | 1,294,493 | | | | | | 98,459,137 | | |
Shopify, Inc., Class A (Canada)* | | | | | 2,692,724 | | | | | | 93,787,577 | | |
StoneCo Ltd., Class A (Brazil)* | | | | | 2,765,473 | | | | | | 26,493,231 | | |
Toast, Inc., Class A* | | | | | 1,654,495 | | | | | | 26,438,830 | | |
Twilio, Inc., Class A* | | | | | 767,497 | | | | | | 65,083,746 | | |
Total IT Services | | | | | | | | | | | 355,460,987 | | |
Investments | | | Shares | | | Value | | ||||||
Real Estate Management & Development – 3.1% | | ||||||||||||
Zillow Group, Inc., Class C* | | | | | 842,301 | | | | | $ | 29,379,459 | | |
Semiconductors & Semiconductor Equipment – 1.0% | | | |||||||||||
NVIDIA Corp. | | | | | 52,760 | | | | | | 9,582,799 | | |
Software – 10.6% | | | | ||||||||||
Bill.com Holdings, Inc.* | | | | | 179,144 | | | | | | 24,198,772 | | |
Intuit, Inc. | | | | | 32,871 | | | | | | 14,994,764 | | |
UiPath, Inc., Class A* | | | | | 3,266,847 | | | | | | 59,881,305 | | |
Total Software | | | | | | | | | | | 99,074,841 | | |
Total Common Stocks (Cost $2,271,779,875) | | | | | | | | | | | 933,001,299 | | |
MONEY MARKET FUND – 0.6% | | | | ||||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 1.83%(e) (Cost $5,456,756) | | | | | 5,456,756 | | | | | | 5,456,756 | | |
Total Investments – 100.2% (Cost $2,277,236,631) | | | | | | | | | | | 938,458,055 | | |
Liabilities in Excess of Other Assets – (0.2)% | | | | | | | | | | | (2,026,508) | | |
Net Assets – 100.0% | | | | | | | | | | $ | 936,431,547 | | |
ARK Fintech Innovation ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 932,995,228 | | | | | | — | | | | | $ | 6,071 | | | | | $ | 933,001,299 | | |
Money Market Fund | | | | | 5,456,756 | | | | | | — | | | | | | — | | | | | | 5,456,756 | | |
Total | | | | $ | 938,451,984 | | | | | | — | | | | | $ | 6,071 | | | | | $ | 938,458,055 | | |
Investments | | | Shares | | | Value | | ||||||
COMMON STOCKS – 94.4% | | | | ||||||||||
Aerospace & Defense – 33.2% | | ||||||||||||
AeroVironment, Inc.* | | | | | 243,494 | | | | | $ | 21,096,320 | | |
Airbus SE (France) | | | | | 33,697 | | | | | | 3,612,053 | | |
Archer Aviation, Inc., Class A* | | | | | 1,947,825 | | | | | | 7,869,213 | | |
Elbit Systems Ltd. (Israel) | | | | | 28,945 | | | | | | 6,707,425 | | |
HEICO Corp. | | | | | 22,269 | | | | | | 3,512,044 | | |
Kratos Defense & Security Solutions, Inc.* | | | | | 1,766,084 | | | | | | 25,413,949 | | |
L3Harris Technologies, Inc. | | | | | 77,026 | | | | | | 18,483,929 | | |
Lockheed Martin Corp. | | | | | 7,728 | | | | | | 3,197,924 | | |
Mynaric AG (Germany)*(a) | | | | | 553,583 | | | | | | 4,838,315 | | |
Spirit AeroSystems Holdings, Inc., Class A | | | | | 170,241 | | | | | | 5,587,310 | | |
Thales SA (France) | | | | | 46,253 | | | | | | 5,736,539 | | |
Total Aerospace & Defense | | | | | | | | | | | 106,055,021 | | |
Air Freight & Logistics – 2.6% | | ||||||||||||
JD Logistics, Inc. (China)*(b) | | | | | 4,156,626 | | | | | | 8,451,031 | | |
Airlines – 5.4% | | ||||||||||||
Blade Air Mobility, Inc.* | | | | | 1,801,632 | | | | | | 10,008,066 | | |
Joby Aviation, Inc.* | | | | | 1,292,910 | | | | | | 7,162,721 | | |
Total Airlines | | | | | | | | | | | 17,170,787 | | |
Diversified Telecommunication – 7.6% | | ||||||||||||
Iridium Communications, Inc.* | | | | | 541,165 | | | | | | 24,195,487 | | |
Electronic Equipment, Instruments & Components – 11.8% | | ||||||||||||
Teledyne Technologies, Inc.* | | | | | 8,715 | | | | | | 3,411,051 | | |
Trimble, Inc.* | | | | | 495,892 | | | | | | 34,429,782 | | |
Total Electronic Equipment, Instruments & Components | | | | | | | | | | | 37,840,833 | | |
Household Durables – 2.4% | | ||||||||||||
Garmin Ltd. | | | | | 78,433 | | | | | | 7,656,629 | | |
Industrial Conglomerates – 1.4% | | ||||||||||||
Honeywell International, Inc. | | | | | 23,872 | | | | | | 4,594,405 | | |
Interactive Media & Services – 2.1% | | ||||||||||||
Alphabet, Inc., Class C* | | | | | 58,792 | | | | | | 6,857,499 | | |
Internet & Direct Marketing Retail – 2.9% | | ||||||||||||
Amazon.com, Inc.* | | | | | 67,426 | | | | | | 9,099,139 | | |
Machinery – 10.7% | | ||||||||||||
Deere & Co. | | | | | 25,374 | | | | | | 8,707,849 | | |
Komatsu Ltd. (Japan) | | | | | 584,788 | | | | | | 13,195,554 | | |
Markforged Holding Corp.* | | | | | 2,170,334 | | | | | | 4,753,031 | | |
Proto Labs, Inc.* | | | | | 28,737 | | | | | | 1,404,952 | | |
Velo3D, Inc.* | | | | | 1,875,675 | | | | | | 6,020,917 | | |
Total Machinery | | | | | | | | | | | 34,082,303 | | |
Investments | | | Shares | | | Value | | ||||||
Semiconductors & Semiconductor Equipment – 2.7% | | ||||||||||||
Teradyne, Inc. | | | | | 85,004 | | | | | $ | 8,576,054 | | |
Software – 9.7% | | ||||||||||||
ANSYS, Inc.* | | | | | 11,180 | | | | | | 3,119,108 | | |
Dassault Systemes SE (France) | | | | | 232,900 | | | | | | 9,916,513 | | |
Synopsys, Inc.* | | | | | 11,783 | | | | | | 4,330,253 | | |
UiPath, Inc., Class A* | | | | | 484,977 | | | | | | 8,889,628 | | |
Unity Software, Inc.* | | | | | 122,918 | | | | | | 4,595,904 | | |
Total Software | | | | | | | | | | | 30,851,406 | | |
Technology Hardware, Storage & Peripherals – 1.9% | | ||||||||||||
3D Systems Corp.* | | | | | 532,495 | | | | | | 6,091,743 | | |
Total Common Stocks (Cost $409,457,723) | | | | | | | | | | | 301,522,337 | | |
EXCHANGE-TRADED FUND – 5.5% | | ||||||||||||
Equity Fund – 5.5% | | ||||||||||||
The 3D Printing ETF† (Cost $29,959,499) | | | | | 763,815 | | | | | | 17,689,955 | | |
MONEY MARKET FUND – 0.1% | | | | ||||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 1.83%(c) (Cost $376,616) | | | | | 376,616 | | | | | | 376,616 | | |
Total Investments – 100.0% (Cost $439,793,838) | | | | | | | | | | | 319,588,908 | | |
Liabilities in Excess of Other Assets – (0.0)%(d) | | | | | (53,091) | | | ||||||
Net Assets – 100.0% | | | | | | | | | | $ | 319,535,817 | | |
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 7/31/2022 | | | Value ($) at 7/31/2022 | | ||||||||||||||||||||||||
Exchange-Traded Fund — 5.5% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Equity Fund — 5.5% | | ||||||||||||||||||||||||||||||||||||||||||||||||
The 3D Printing ETF | | ||||||||||||||||||||||||||||||||||||||||||||||||
41,642,604 | | | | | 6,315,301 | | | | | | (14,688,369) | | | | | | (4,506,722) | | | | | | (11,072,859) | | | | | | 604 | | | | | | — | | | | | | 763,815 | | | | | | 17,689,955 | | |
$41,642,604 | | | | $ | 6,315,301 | | | | | $ | (14,688,369) | | | | | $ | (4,506,722) | | | | | $ | (11,072,859) | | | | | $ | 604 | | | | | $ | — | | | | | | 763,815 | | | | | $ | 17,689,955 | | |
ARK Space Exploration & Innovation ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 301,522,337 | | | | | $ | — | | | | | $ | — | | | | | $ | 301,522,337 | | |
Exchange – Traded Fund | | | | | 17,689,955 | | | | | | — | | | | | | — | | | | | | 17,689,955 | | |
Money Market Fund | | | | | 376,616 | | | | | | — | | | | | | — | | | | | | 376,616 | | |
Total | | | | $ | 319,588,908 | | | | | $ | — | | | | | $ | — | | | | | $ | 319,588,908 | | |
Investments | | | Shares | | | Value | | ||||||
COMMON STOCKS – 99.8% | | | | ||||||||||
Aerospace & Defense – 2.5% | | ||||||||||||
Aerojet Rocketdyne Holdings, Inc.* | | | | | 57,056 | | | | | $ | 2,492,777 | | |
Hexcel Corp. | | | | | 4,256 | | | | | | 257,530 | | |
Moog, Inc., Class A | | | | | 28,613 | | | | | | 2,450,417 | | |
Total Aerospace & Defense | | | | | | | | | | | 5,200,724 | | |
Air Freight & Logistics – 1.2% | | ||||||||||||
United Parcel Service, Inc., Class B | | | | | 12,517 | | | | | | 2,439,438 | | |
Auto Components – 2.3% | | ||||||||||||
Cie Generale des Etablissements Michelin SCA (France) | | | | | 84,894 | | | | | | 2,356,986 | | |
Exco Technologies Ltd. (Canada) | | | | | 371,949 | | | | | | 2,538,623 | | |
Total Auto Components | | | | | | | | | | | 4,895,609 | | |
Chemicals – 0.7% | | ||||||||||||
Arkema SA (France) | | | | | 2,698 | | | | | | 254,515 | | |
DuPont de Nemours, Inc. | | | | | 4,243 | | | | | | 259,799 | | |
Eastman Chemical Co. | | | | | 2,540 | | | | | | 243,662 | | |
Evonik Industries AG (Germany) | | | | | 11,879 | | | | | | 252,288 | | |
Koninklijke DSM NV (Netherlands) | | | | | 1,601 | | | | | | 255,098 | | |
Toray Industries, Inc. (Japan) | | | | | 43,853 | | | | | | 240,920 | | |
Total Chemicals | | | | | | | | | | | 1,506,282 | | |
Commercial Services & Supplies – 0.9% | | ||||||||||||
PyroGenesis Canada, Inc. (Canada)* | | | | | 138,798 | | | | | | 208,108 | | |
Shapeways Holdings, Inc.* | | | | | 1,954,678 | | | | | | 1,673,204 | | |
Total Commercial Services & Supplies | | | | | | | | | | | 1,881,312 | | |
Electrical Equipment – 1.8% | | ||||||||||||
AMETEK, Inc. | | | | | 28,781 | | | | | | 3,554,454 | | |
SGL Carbon SE (Germany)* | | | | | 38,499 | | | | | | 289,796 | | |
Total Electrical Equipment | | | | | | | | | | | 3,844,250 | | |
Electronic Equipment, Instruments & Components – 12.8% | | ||||||||||||
FARO Technologies, Inc.* | | | | | 238,546 | | | | | | 7,757,516 | | |
Hexagon AB, Class B (Sweden) | | | | | 306,752 | | | | | | 3,590,576 | | |
Renishaw PLC (United Kingdom) | | | | | 128,446 | | | | | | 6,785,590 | | |
Trimble, Inc.* | | | | | 124,143 | | | | | | 8,619,249 | | |
Total Electronic Equipment, Instruments & Components | | | | | | | | | | | 26,752,931 | | |
Health Care Equipment & Supplies – 5.8% | | ||||||||||||
Align Technology, Inc.* | | | | | 12,605 | | | | | | 3,541,627 | | |
Conformis, Inc.* | | | | | 7,239,109 | | | | | | 1,889,408 | | |
Straumann Holding AG (Switzerland) | | | | | 49,285 | | | | | | 6,617,243 | | |
Total Health Care Equipment & Supplies | | | | | | | | | | | 12,048,278 | | |
Investments | | | Shares | | | Value | | ||||||
Industrial Conglomerates – 2.6% | | ||||||||||||
3M Co. | | | | | 1,807 | | | | | $ | 258,835 | | |
General Electric Co. | | | | | 36,529 | | | | | | 2,699,858 | | |
Siemens AG (Germany) | | | | | 23,091 | | | | | | 2,561,550 | | |
Total Industrial Conglomerates | | | | | | | | | | | 5,520,243 | | |
Internet & Direct Marketing Retail – 3.2% | | ||||||||||||
Xometry, Inc., Class A* | | | | | 176,631 | | | | | | 6,711,978 | | |
Life Sciences Tools & Services – 1.6% | | ||||||||||||
BICO Group AB (Sweden)* | | | | | 840,930 | | | | | | 3,314,996 | | |
Machinery – 19.4% | | ||||||||||||
Desktop Metal, Inc., Class A* | | | | | 2,237,286 | | | | | | 4,765,419 | | |
Fathom Digital Manufacturing C* | | | | | 1,094,827 | | | | | | 4,685,860 | | |
Lincoln Electric Holdings, Inc. | | | | | 18,658 | | | | | | 2,638,987 | | |
Markforged Holding Corp.* | | | | | 2,592,583 | | | | | | 5,677,757 | | |
Massivit 3d Printing Technologies Ltd. (Israel)* | | | | | 185,574 | | | | | | 557,407 | | |
OC Oerlikon Corp. AG (Switzerland) | | | | | 332,930 | | | | | | 2,565,574 | | |
Proto Labs, Inc.* | | | | | 128,771 | | | | | | 6,295,614 | | |
Sandvik AB (Sweden) | | | | | 13,505 | | | | | | 247,383 | | |
SLM Solutions Group AG (Germany)* | | | | | 523,645 | | | | | | 6,475,787 | | |
Velo3D, Inc.* | | | | | 2,091,641 | | | | | | 6,714,168 | | |
Total Machinery | | | | | | | | | | | 40,623,956 | | |
Metals & Mining – 2.6% | | ||||||||||||
Arconic Corp.* | | | | | 79,638 | | | | | | 2,405,864 | | |
ATI Inc.* | | | | | 10,042 | | | | | | 249,945 | | |
Carpenter Technology Corp. | | | | | 8,259 | | | | | | 265,444 | | |
Kaiser Aluminum Corp. | | | | | 30,006 | | | | | | 2,273,555 | | |
voestalpine AG (Austria) | | | | | 11,868 | | | | | | 265,639 | | |
Total Metals & Mining | | | | | | | | | | | 5,460,447 | | |
Shell Companies – 2.8% | | ||||||||||||
Atlantic Coastal Acquisition Corp., Class A* | | | | | 604,595 | | | | | | 5,931,077 | | |
Software – 26.9% | | ||||||||||||
Altair Engineering, Inc., Class A* | | | | | 140,878 | | | | | | 8,299,123 | | |
ANSYS, Inc.* | | | | | 30,255 | | | | | | 8,440,843 | | |
Autodesk, Inc.* | | | | | 40,682 | | | | | | 8,800,330 | | |
Dassault Systemes SE (France) | | | | | 190,408 | | | | | | 8,107,271 | | |
Materialise NV (Belgium)*(a) | | | | | 437,685 | | | | | | 6,145,097 | | |
Microsoft Corp. | | | | | 27,911 | | | | | | 7,835,734 | | |
PTC, Inc.* | | | | | 70,738 | | | | | | 8,727,655 | | |
Total Software | | | | | | | | | | | 56,356,053 | | |
Investments | | | Shares | | | Value | | ||||||
Technology Hardware, Storage & Peripherals – 12.7% | | ||||||||||||
3D Systems Corp.* | | | | | 621,090 | | | | | $ | 7,105,270 | | |
Eastman Kodak Co.* | | | | | 46,502 | | | | | | 256,226 | | |
HP, Inc. | | | | | 189,834 | | | | | | 6,338,557 | | |
Nano Dimension Ltd. (Israel)*(a) | | | | | 1,746,013 | | | | | | 5,744,383 | | |
Stratasys Ltd.* | | | | | 330,699 | | | | | | 6,809,092 | | |
Xerox Holdings Corp. | | | | | 16,350 | | | | | | 280,076 | | |
Total Technology Hardware, Storage & Peripherals | | | | | | | | | | | 26,533,604 | | |
Total Common Stocks (Cost $330,851,342) | | | | | | | | | | | 209,021,178 | | |
PREFERRED STOCK – 0.1% | | ||||||||||||
Household Products – 0.1% | | ||||||||||||
Henkel AG & Co. KGaA (Germany) (Cost $383,545) | | | | | 3,754 | | | | | | 238,953 | | |
Investments | | | Shares | | | Value | | ||||||
MONEY MARKET FUND – 0.1% | | ||||||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 1.83%(b) (Cost $273,185) | | | | | 273,185 | | | | | $ | 273,185 | | |
Total Investments – 100.0% (Cost $331,508,072) | | | | | | | | | | | 209,533,316 | | |
Other Assets in Excess of Liabilities – 0.0%(c) | | | | | 16,976 | | | ||||||
Net Assets – 100.0% | | | | | | | | | | $ | 209,550,292 | | |
Value ($) at 7/31/2021 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 7/31/2022 | | | Value ($) at 7/31/2022 | | ||||||||||||||||||||||||
Common Stock — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Commercial Services & Supplies — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Shapeways Holdings, Inc.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
— | | | | | 8,080,687 | | | | | | (1,145,418) | | | | | | (1,553,949) | | | | | | (3,708,116) | | | | | | — | | | | | | — | | | | | | 1,954,678 | | | | | | 1,673,204 | | |
Health Care Equipment & Supplies — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
Conformis, Inc.^ | | ||||||||||||||||||||||||||||||||||||||||||||||||
19,209,575 | | | | | 5,760,620 | | | | | | (5,893,761) | | | | | | (6,360,283) | | | | | | (10,826,743) | | | | | | — | | | | | | — | | | | | | 7,239,109 | | | | | | 1,889,408 | | |
Machinery — 0.0% | | ||||||||||||||||||||||||||||||||||||||||||||||||
ExOne (The) Co. | | ||||||||||||||||||||||||||||||||||||||||||||||||
18,815,801 | | | | | — | | | | | | (35,228,058) | | | | | | (6,866,123) | | | | | | 23,278,380 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
$38,025,376 | | | | $ | 13,841,307 | | | | | $ | (42,267,237) | | | | | $ | (14,780,355) | | | | | $ | 8,743,521 | | | | | $ | — | | | | | $ | — | | | | | | 9,193,787 | | | | | $ | 3,562,612 | | |
The 3D Printing ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 209,021,178 | | | | | $ | — | | | | | $ | — | | | | | $ | 209,021,178 | | |
Preferred Stock‡ | | | | | 238,953 | | | | | | — | | | | | | — | | | | | | 238,953 | | |
Money Market Fund | | | | | 273,185 | | | | | | — | | | | | | — | | | | | | 273,185 | | |
Total | | | | $ | 209,533,316 | | | | | $ | — | | | | | $ | — | | | | | $ | 209,533,316 | | |
Investments | | | Shares | | | Value | | ||||||
COMMON STOCKS – 99.4% | | | | ||||||||||
Aerospace & Defense – 4.4% | | ||||||||||||
Elbit Systems Ltd. (Israel) | | | | | 11,244 | | | | | $ | 2,563,942 | | |
RADA Electronic Industries Ltd. (Israel)* | | | | | 261,170 | | | | | | 2,643,041 | | |
Total Aerospace & Defense | | | | | | | | | | | 5,206,983 | | |
Biotechnology – 2.2% | | ||||||||||||
Enlivex Therapeutics Ltd. (Israel)* | | | | | 64,500 | | | | | | 274,125 | | |
UroGen Pharma Ltd.* | | | | | 291,303 | | | | | | 2,283,816 | | |
Total Biotechnology | | | | | | | | | | | 2,557,941 | | |
Communications Equipment – 13.3% | | ||||||||||||
AudioCodes Ltd. (Israel) | | | | | 107,862 | | | | | | 2,621,047 | | |
Ceragon Networks Ltd. (Israel)* | | | | | 953,973 | | | | | | 2,480,330 | | |
Gilat Satellite Networks Ltd. (Israel)* | | | | | 379,697 | | | | | | 2,513,594 | | |
Ituran Location and Control Ltd. (Israel) | | | | | 102,006 | | | | | | 2,590,952 | | |
Radware Ltd. (Israel)* | | | | | 111,606 | | | | | | 2,581,447 | | |
Silicom Ltd. (Israel)* | | | | | 68,587 | | | | | | 2,879,968 | | |
Total Communications Equipment | | | | | | | | | | | 15,667,338 | | |
Diversified Telecommunication – 2.2% | | ||||||||||||
Bezeq The Israeli Telecommunication Corp. Ltd. (Israel) | | | | | 1,538,298 | | | | | | 2,612,593 | | |
Entertainment – 2.0% | | ||||||||||||
Playtika Holding Corp.* | | | | | 192,478 | | | | | | 2,361,705 | | |
Health Care Equipment & Supplies – 4.3% | | ||||||||||||
Inmode Ltd.* | | | | | 85,421 | | | | | | 2,839,394 | | |
Nano-X Imaging Ltd. (Israel)* | | | | | 186,628 | | | | | | 2,247,001 | | |
Total Health Care Equipment & Supplies | | | | | | | | | | | 5,086,395 | | |
Hotels, Restaurants & Leisure – 2.1% | | ||||||||||||
Fattal Holdings 1998 Ltd. (Israel)* | | | | | 21,957 | | | | | | 2,525,686 | | |
Interactive Media & Services – 1.9% | | ||||||||||||
Taboola.com Ltd. (Israel)* | | | | | 847,510 | | | | | | 2,220,476 | | |
Internet & Direct Marketing Retail – 1.8% | | ||||||||||||
Fiverr International Ltd.* | | | | | 66,235 | | | | | | 2,124,819 | | |
IT Services – 9.0% | | ||||||||||||
HUB Cyber Security Israel Ltd. (Israel)* | | | | | 750,223 | | | | | | 1,030,997 | | |
Malam – Team Ltd. (Israel) | | | | | 106,188 | | | | | | 2,357,963 | | |
Matrix IT Ltd. (Israel) | | | | | 100,998 | | | | | | 2,535,090 | | |
One Software Technologies Ltd. (Israel) | | | | | 157,950 | | | | | | 2,568,723 | | |
Wix.com Ltd. (Israel)* | | | | | 37,640 | | | | | | 2,233,181 | | |
Total IT Services | | | | | | | | | | | 10,725,954 | | |
Life Sciences Tools & Services – 1.6% | | ||||||||||||
Compugen Ltd. (Israel)* | | | | | 1,196,958 | | | | | | 1,927,102 | | |
Media – 2.0% | | ||||||||||||
Perion Network Ltd. (Israel)* | | | | | 127,403 | | | | | | 2,386,258 | | |
Pharmaceuticals – 4.7% | | ||||||||||||
Taro Pharmaceutical Industries Ltd.* | | | | | 63,375 | | | | | | 2,261,854 | | |
Teva Pharmaceutical Industries Ltd. (Israel)*(a) | | | | | 346,906 | | | | | | 3,253,978 | | |
Total Pharmaceuticals | | | | | | | | | | | 5,515,832 | | |
Professional Services – 2.1% | | ||||||||||||
Danel Adir Yeoshua Ltd. (Israel) | | | | | 19,601 | | | | | | 2,450,738 | | |
Investments | | | Shares | | | Value | | ||||||
Semiconductors & Semiconductor Equipment – 6.5% | | ||||||||||||
Camtek Ltd. (Israel)* | | | | | 84,748 | | | | | $ | 2,470,404 | | |
Nova Ltd. (Israel)* | | | | | 24,911 | | | | | | 2,624,374 | | |
Tower Semiconductor Ltd. (Israel)* | | | | | 54,816 | | | | | | 2,623,494 | | |
Total Semiconductors & Semiconductor Equipment | | | | | | | | | | | 7,718,272 | | |
Software – 32.8% | | | | ||||||||||
Allot Ltd. (Israel)* | | | | | 445,615 | | | | | | 2,277,093 | | |
Cellebrite DI Ltd. (Japan)* | | | | | 438,663 | | | | | | 2,215,248 | | |
Check Point Software Technologies Ltd. (Israel)* | | | | | 19,734 | | | | | | 2,458,856 | | |
Cognyte Software Ltd. (Israel)* | | | | | 570,776 | | | | | | 2,574,200 | | |
CyberArk Software Ltd.* | | | | | 17,981 | | | | | | 2,339,867 | | |
Hilan Ltd. (Israel) | | | | | 43,512 | | | | | | 2,502,566 | | |
ironSource Ltd., Class A (Israel)* | | | | | 597,892 | | | | | | 2,331,779 | | |
JFrog Ltd. (Israel)* | | | | | 111,489 | | | | | | 2,475,056 | | |
Magic Software Enterprises Ltd. (Israel) | | | | | 128,361 | | | | | | 2,538,785 | | |
Monday.com Ltd.* | | | | | 23,106 | | | | | | 2,373,679 | | |
Nice Ltd. (Israel)*(a) | | | | | 11,930 | | | | | | 2,553,258 | | |
Riskified Ltd., Class A* | | | | | 600,376 | | | | | | 2,635,651 | | |
Sapiens International Corp. NV (Israel) | | | | | 99,514 | | | | | | 2,618,213 | | |
SimilarWeb Ltd. (Israel)* | | | | | 238,360 | | | | | | 1,985,539 | | |
Tufin Software Technologies Ltd. (Israel)* | | | | | 201,054 | | | | | | 2,487,038 | | |
WalkMe Ltd. (Israel)* | | | | | 258,459 | | | | | | 2,429,515 | | |
Total Software | | | | | | | | | | | 38,796,343 | | |
Technology Hardware, Storage & Peripherals – 2.2% | | ||||||||||||
Stratasys Ltd.* | | | | | 126,022 | | | | | | 2,594,793 | | |
Wireless Telecommunication Services – 4.3% | | ||||||||||||
Cellcom Israel Ltd. (Israel)* | | | | | 467,862 | | | | | | 2,528,463 | | |
Partner Communications Co. Ltd. (Israel)* | | | | | 318,965 | | | | | | 2,517,638 | | |
Total Wireless Telecommunication Services | | | | | | | | | | | 5,046,101 | | |
Total Common Stocks (Cost $159,707,917) | | | | | | | | | | | 117,525,329 | | |
Total Investments – 99.4% (Cost $159,707,917) | | | | | | | | | | | 117,525,329 | | |
Other Assets in Excess of Liabilities – 0.6% | | | | | 608,760 | | | ||||||
Net Assets – 100.0% | | | | | | | | | | $ | 118,134,089 | | |
Country | | | Value | | | % of Net Assets | | ||||||
Israel | | | | $ | 93,494,503 | | | | | | 79.1% | | |
Japan | | | | | 2,215,248 | | | | | | 1.9 | | |
United States | | | | | 21,815,578 | | | | | | 18.5 | | |
Total Investments | | | | | 117,525,329 | | | | | | 99.5 | | |
Other Assets in Excess of Liabilities | | | | | 608,760 | | | | | | 0.5 | | |
Net Assets | | | | $ | 118,134,089 | | | | | | 100.0% | | |
The ARK Israel Innovative Technology ETF | | | Level 1 | | | Level 2 | | | Level 3 | | | Total | | ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Common Stocks‡ | | | | $ | 117,525,329 | | | | | $ | — | | | | | $ | — | | | | | $ | 117,525,329 | | |
Total | | | | $ | 117,525,329 | | | | | $ | — | | | | | $ | — | | | | | $ | 117,525,329 | | |
| | | ARK Genomic Revolution ETF | | | ARK Autonomous Technology & Robotics ETF | | | ARK Innovation ETF | | | ARK Next Generation Internet ETF | | ||||||||||||
ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities at market value (Note 2) | | | | $ | 2,110,073,876 | | | | | $ | 1,062,616,193 | | | | | $ | 4,918,835,562 | | | | | $ | 1,424,872,285 | | |
Investments in affiliated securities at market value (Note 2) | | | | | 673,558,993 | | | | | | 149,719,952 | | | | | | 4,420,973,364 | | | | | | 32,529,639 | | |
Cash | | | | | — | | | | | | — | | | | | | 2,737,598 | | | | | | 429,120 | | |
Receivables: | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends and interest | | | | | 244,028 | | | | | | 315,924 | | | | | | 28,850 | | | | | | 1,217 | | |
Capital shares sold | | | | | — | | | | | | — | | | | | | 13,848,772 | | | | | | — | | |
Investment securities sold | | | | | 36,627,342 | | | | | | — | | | | | | 57,057,771 | | | | | | 5,138,013 | | |
Tax reclaims | | | | | 5,173,433 | | | | | | 9,177 | | | | | | 1,778,642 | | | | | | — | | |
Total Assets | | | | | 2,825,677,672 | | | | | | 1,212,661,246 | | | | | | 9,415,260,559 | | | | | | 1,462,970,274 | | |
LIABILITIES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Payables: | | | | | | | | | | | | | | | | | | | | | | | | | |
Capital shares purchased | | | | | 25,700,634 | | | | | | — | | | | | | 22,825,172 | | | | | | — | | |
Investment securities purchased | | | | | 18,162,397 | | | | | | — | | | | | | 49,766,057 | | | | | | 5,554,431 | | |
Management fees (Note 3) | | | | | 1,788,917 | | | | | | 722,496 | | | | | | 5,850,311 | | | | | | 916,664 | | |
Total Liabilities | | | | | 45,651,948 | | | | | | 722,496 | | | | | | 78,441,540 | | | | | | 6,471,095 | | |
NET ASSETS | | | | $ | 2,780,025,724 | | | | | $ | 1,211,938,750 | | | | | $ | 9,336,819,019 | | | | | $ | 1,456,499,179 | | |
NET ASSETS CONSIST OF: | | | | | | | | | | | | | | | | | | | | | | | | | |
Paid-in capital | | | | $ | 7,598,011,751 | | | | | $ | 1,981,479,815 | | | | | $ | 23,388,439,361 | | | | | $ | 4,275,533,919 | | |
Total accumulated loss | | | | | (4,817,986,027) | | | | | | (769,541,065) | | | | | | (14,051,620,342) | | | | | | (2,819,034,740) | | |
NET ASSETS | | | | $ | 2,780,025,724 | | | | | $ | 1,211,938,750 | | | | | $ | 9,336,819,019 | | | | | $ | 1,456,499,179 | | |
Shares outstanding no par value (unlimited shares authorized) | | | | | 75,805,000 | | | | | | 21,600,000 | | | | | | 206,850,000 | | | | | | 26,700,000 | | |
Net asset value, per share | | | | $ | 36.67 | | | | | $ | 56.11 | | | | | $ | 45.14 | | | | | $ | 54.55 | | |
Investments in non-affiliated securities at cost | | | | $ | 4,981,170,618 | | | | | $ | 1,601,136,348 | | | | | $ | 10,588,486,730 | | | | | $ | 3,720,357,957 | | |
Investments in affiliated securities at cost | | | | $ | 2,096,772,821 | | | | | $ | 344,180,460 | | | | | $ | 10,714,094,998 | | | | | $ | 69,280,847 | | |
| | | ARK Fintech Innovation ETF | | | ARK Space Exploration & Innovation ETF | | | The 3D Printing ETF | | | The ARK Israel Innovative Technology ETF | | ||||||||||||
ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities at market value (Note 2) | | | | $ | 938,458,055 | | | | | $ | 301,898,953 | | | | | $ | 209,533,316 | | | | | $ | 117,525,329 | | |
Investments in affiliated securities at market value (Note 2) | | | | | — | | | | | | 17,689,955 | | | | | | — | | | | | | — | | |
Cash | | | | | 636,866 | | | | | | — | | | | | | — | | | | | | 474,007 | | |
Foreign currency | | | | | — | | | | | | — | | | | | | — | | | | | | 392,253 | | |
Receivables: | | | | | | | | | | | | | | | | | | | | | | | | | |
Dividends and interest | | | | | 2,627 | | | | | | 30,188 | | | | | | 28,567 | | | | | | 148 | | |
Investment securities sold | | | | | 6,001,222 | | | | | | — | | | | | | 202,993 | | | | | | 851,127 | | |
Tax reclaims | | | | | 10,511 | | | | | | 102,124 | | | | | | 184,123 | | | | | | — | | |
Total Assets | | | | | 945,109,281 | | | | | | 319,721,220 | | | | | | 209,948,999 | | | | | | 119,242,864 | | |
LIABILITIES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Due to custodian for foreign currency | | | | | 4,360,239 | | | | | | 3,700 | | | | | | 49,990 | | | | | | — | | |
Payables: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investment securities purchased | | | | | 3,752,121 | | | | | | — | | | | | | 237,205 | | | | | | 1,059,805 | | |
Management fees (Note 3) | | | | | 565,374 | | | | | | 181,703 | | | | | | 109,817 | | | | | | 47,964 | | |
Other accrued expenses | | | | | — | | | | | | — | | | | | | 1,695 | | | | | | 1,006 | | |
Total Liabilities | | | | | 8,677,734 | | | | | | 185,403 | | | | | | 398,707 | | | | | | 1,108,775 | | |
NET ASSETS | | | | $ | 936,431,547 | | | | | $ | 319,535,817 | | | | | $ | 209,550,292 | | | | | $ | 118,134,089 | | |
NET ASSETS CONSIST OF: | | | | | | | | | | | | | | | | | | | | | | | | | |
Paid-in capital | | | | $ | 2,999,357,909 | | | | | $ | 468,059,020 | | | | | $ | 446,955,206 | | | | | $ | 242,250,967 | | |
Total accumulated loss | | | | | (2,062,926,362) | | | | | | (148,523,203) | | | | | | (237,404,914) | | | | | | (124,116,878) | | |
NET ASSETS | | | | $ | 936,431,547 | | | | | $ | 319,535,817 | | | | | $ | 209,550,292 | | | | | $ | 118,134,089 | | |
Shares outstanding no par value (unlimited shares authorized) | | | | | 52,300,001 | | | | | | 21,400,001 | | | | | | 9,050,001 | | | | | | 6,100,001 | | |
Net asset value, per share | | | | $ | 17.91 | | | | | $ | 14.93 | | | | | $ | 23.15 | | | | | $ | 19.37 | | |
Investments in non-affiliated securities at cost | | | | $ | 2,277,236,631 | | | | | $ | 409,834,339 | | | | | $ | 331,508,072 | | | | | $ | 159,707,917 | | |
Investments in affiliated securities at cost | | | | $ | — | | | | | $ | 29,959,499 | | | | | $ | — | | | | | $ | — | | |
Foreign currency at cost | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 392,253 | | |
| | | ARK Genomic Revolution ETF | | | ARK Autonomous Technology & Robotics ETF | | | ARK Innovation ETF | | | ARK Next Generation Internet ETF | | ||||||||||||
INVESTMENT INCOME: | | | | | | | | | | | | | | | | | | | | | | | | | |
Unaffiliated dividend income | | | | $ | 7,093,608 | | | | | $ | 6,919,184 | | | | | $ | 724,822 | | | | | $ | 12,173 | | |
Foreign withholding tax | | | | | (603,721) | | | | | | (637,371) | | | | | | (79,832) | | | | | | — | | |
Total Income | | | | | 6,489,887 | | | | | | 6,281,813 | | | | | | 644,990 | | | | | | 12,173 | | |
EXPENSES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Management fees (Note 3) | | | | | 36,549,450 | | | | | | 14,382,558 | | | | | | 109,826,484 | | | | | | 25,369,077 | | |
Overdraft expense | | | | | 71 | | | | | | 29 | | | | | | — | | | | | | 3 | | |
Total Expenses | | | | | 36,549,521 | | | | | | 14,382,587 | | | | | | 109,826,484 | | | | | | 25,369,080 | | |
Net Investment Loss | | | | | (30,059,634) | | | | | | (8,100,774) | | | | | | (109,181,494) | | | | | | (25,356,907) | | |
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY TRANSLATION: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized gain (loss) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities | | | | | (350,563,722) | | | | | | 3,790,238 | | | | | | (1,768,790,020) | | | | | | (437,944,832) | | |
Investments in affiliated securities | | | | | (258,964,589) | | | | | | — | | | | | | (552,126,432) | | | | | | (6,262,035) | | |
In-kind redemptions – non-affiliated securities | | | | | 80,729,152 | | | | | | 100,455,268 | | | | | | 1,367,643,045 | | | | | | 344,476,234 | | |
In-kind redemptions – affiliated securities | | | | | 77,732,186 | | | | | | (13,682,843) | | | | | | 942,103,789 | | | | | | (5,642,091) | | |
Net realized gain (loss) | | | | | (451,066,973) | | | | | | 90,562,663 | | | | | | (11,169,618) | | | | | | (105,372,724) | | |
Change in unrealized appreciation (depreciation) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities | | | | | (2,285,609,696) | | | | | | (563,068,471) | | | | | | (6,455,885,782) | | | | | | (2,576,866,617) | | |
Investments in affiliated securities | | | | | (1,408,652,226) | | | | | | (163,319,150) | | | | | | (6,324,598,841) | | | | | | (24,016,183) | | |
Change in unrealized depreciation | | | | | (3,694,261,922) | | | | | | (726,387,621) | | | | | | (12,780,484,623) | | | | | | (2,600,882,800) | | |
Net realized and unrealized loss on investments and foreign currency translation | | | | | (4,145,328,895) | | | | | | (635,824,958) | | | | | | (12,791,654,241) | | | | | | (2,706,255,524) | | |
Net Decrease in Net Assets Resulting From Operations | | | | $ | (4,175,388,529) | | | | | $ | (643,925,732) | | | | | $ | (12,900,835,735) | | | | | $ | (2,731,612,431) | | |
| | | ARK Fintech Innovation ETF | | | ARK Space Exploration & Innovation ETF | | | The 3D Printing ETF | | | The ARK Israel Innovative Technology ETF | | ||||||||||||
INVESTMENT INCOME: | | | | | | | | | | | | | | | | | | | | | | | | | |
Unaffiliated dividend income | | | | $ | 2,153,427 | | | | | $ | 2,420,658 | | | | | $ | 1,900,317 | | | | | $ | 864,657 | | |
Affiliated dividend income | | | | | — | | | | | | 604 | | | | | | — | | | | | | — | | |
Foreign withholding tax | | | | | (34,812) | | | | | | (133,889) | | | | | | (104,950) | | | | | | (205,471) | | |
Total Income | | | | | 2,118,615 | | | | | | 2,287,373 | | | | | | 1,795,367 | | | | | �� | 659,186 | | |
EXPENSES: | | | | | | | | | | | | | | | | | | | | | | | | | |
Management fees (Note 3) | | | | | 15,713,286 | | | | | | 3,314,423 | | | | | | 2,286,380 | | | | | | 931,222 | | |
Overdraft expense | | | | | 10,729 | | | | | | 1,232 | | | | | | 4,257 | | | | | | 3,455 | | |
Other expenses | | | | | — | | | | | | — | | | | | | 35,080 | | | | | | 19,409 | | |
Total Expenses | | | | | 15,724,015 | | | | | | 3,315,655 | | | | | | 2,325,717 | | | | | | 954,086 | | |
Less expense waivers and reimbursements | | | | | — | | | | | | (213,008)(1) | | | | | | — | | | | | | — | | |
Net Expenses | | | | | 15,724,015 | | | | | | 3,102,647 | | | | | | 2,325,717 | | | | | | 954,086 | | |
Net Investment Loss | | | | | (13,605,400) | | | | | | (815,274) | | | | | | (530,350) | | | | | | (294,900) | | |
NET REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FOREIGN CURRENCY TRANSLATION: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized gain (loss) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities | | | | | (534,798,248) | | | | | | (9,781,904) | | | | | | (85,942,117) | | | | | | (62,619,027) | | |
Investments in affiliated securities | | | | | — | | | | | | (2,638,854) | | | | | | (14,792,631) | | | | | | — | | |
Foreign currency transactions | | | | | (437,903) | | | | | | (23,104) | | | | | | (113,910) | | | | | | (215,462) | | |
In-kind redemptions – non-affiliated securities | | | | | 131,648,233 | | | | | | 5,757,701 | | | | | | (2,505,201) | | | | | | 6,084,932 | | |
In-kind redemptions – affiliated securities | | | | | — | | | | | | (1,867,868) | | | | | | 12,276 | | | | | | — | | |
Net realized loss | | | | | (403,587,918) | | | | | | (8,554,029) | | | | | | (103,341,583) | | | | | | (56,749,557) | | |
Change in unrealized appreciation (depreciation) on: | | | | | | | | | | | | | | | | | | | | | | | | | |
Investments in non-affiliated securities | | | | | (1,364,480,058) | | | | | | (113,709,181) | | | | | | (78,987,471) | | | | | | (18,576,798) | | |
Investments in affiliated securities | | | | | — | | | | | | (11,072,859) | | | | | | 18,488,243 | | | | | | — | | |
Foreign currency translation | | | | | (11,424) | | | | | | (11,078) | | | | | | (11,075) | | | | | | 402 | | |
Change in unrealized depreciation | | | | | (1,364,491,482) | | | | | | (124,793,118) | | | | | | (60,510,303) | | | | | | (18,576,396) | | |
Net realized and unrealized loss on investments and foreign currency translation | | | | | (1,768,079,400) | | | | | | (133,347,147) | | | | | | (163,851,886) | | | | | | (75,325,953) | | |
Net Decrease in Net Assets Resulting From Operations | | | | $ | (1,781,684,800) | | | | | $ | (134,162,421) | | | | | $ | (164,382,236) | | | | | $ | (75,620,853) | | |
| | | ARK Genomic Revolution ETF | | | ARK Autonomous Technology & Robotics ETF | | ||||||||||||||||||
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | ||||||||||||
OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment loss | | | | $ | (30,059,634) | | | | | $ | (19,302,419) | | | | | $ | (8,100,774) | | | | | $ | (8,696,574) | | |
Net realized gain (loss) on investments and foreign currency transactions | | | | | (451,066,973) | | | | | | 1,031,287,805 | | | | | | 90,562,663 | | | | | | 327,433,269 | | |
Net change in unrealized depreciation on investments and foreign currency translations | | | | | (3,694,261,922) | | | | | | (1,002,959,757) | | | | | | (726,387,621) | | | | | | (98,689,408) | | |
Net increase (decrease) in net assets resulting from operations | | | | | (4,175,388,529) | | | | | | 9,025,629 | | | | | | (643,925,732) | | | | | | 220,047,287 | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | (32,103,552) | | | | | | (62,384,714) | | | | | | (17,227,749) | | | | | | (14,434,200) | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | 2,552,890,394 | | | | | | 10,605,437,472 | | | | | | 32,917,320 | | | | | | 3,123,783,591 | | |
Cost of shares redeemed | | | | | (4,153,386,338) | | | | | | (3,553,920,853) | | | | | | (966,464,826) | | | | | | (970,644,388) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | (1,600,495,944) | | | | | | 7,051,516,619 | | | | | | (933,547,506) | | | | | | 2,153,139,203 | | |
Increase (decrease) in net assets | | | | | (5,807,988,025) | | | | | | 6,998,157,534 | | | | | | (1,594,700,987) | | | | | | 2,358,752,290 | | |
NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning of year | | | | | 8,588,013,749 | | | | | | 1,589,856,215 | | | | | | 2,806,639,737 | | | | | | 447,887,447 | | |
End of year | | | | $ | 2,780,025,724 | | | | | $ | 8,588,013,749 | | | | | $ | 1,211,938,750 | | | | | $ | 2,806,639,737 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares outstanding, beginning of year | | | | | 101,755,000 | | | | | | 29,605,000 | | | | | | 34,600,000 | | | | | | 8,500,000 | | |
Shares sold | | | | | 51,950,000 | | | | | | 113,400,000 | | | | | | 500,000 | | | | | | 38,100,000 | | |
Shares redeemed | | | | | (77,900,000) | | | | | | (41,250,000) | | | | | | (13,500,000) | | | | | | (12,000,000) | | |
Shares outstanding, end of year | | | | | 75,805,000 | | | | | | 101,755,000 | | | | | | 21,600,000 | | | | | | 34,600,000 | | |
| | | ARK Innovation ETF | | | ARK Next Generation Internet ETF | | ||||||||||||||||||
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | ||||||||||||
OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment loss | | | | $ | (109,181,494) | | | | | $ | (112,129,063) | | | | | $ | (25,356,907) | | | | | $ | (35,094,816) | | |
Net realized gain (loss) on investments and foreign currency transactions | | | | | (11,169,618) | | | | | | 4,139,590,008 | | | | | | (105,372,724) | | | | | | 1,184,280,101 | | |
Net change in unrealized depreciation on investments and foreign currency translations | | | | | (12,780,484,623) | | | | | | (1,127,085,783) | | | | | | (2,600,882,800) | | | | | | (245,805,204) | | |
Net increase (decrease) in net assets resulting from operations | | | | | (12,900,835,735) | | | | | | 2,900,375,162 | | | | | | (2,731,612,431) | | | | | | 903,380,081 | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | (133,975,984) | | | | | | (291,314,175) | | | | | | (106,224,276) | | | | | | (68,580,176) | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | 18,069,518,927 | | | | | | 24,078,752,000 | | | | | | 1,093,086,885 | | | | | | 6,018,769,322 | | |
Cost of shares redeemed | | | | | (18,193,317,043) | | | | | | (10,324,983,217) | | | | | | (2,612,390,915) | | | | | | (2,959,974,254) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | (123,798,116) | | | | | | 13,753,768,783 | | | | | | (1,519,304,030) | | | | | | 3,058,795,068 | | |
Increase (decrease) in net assets | | | | | (13,158,609,835) | | | | | | 16,362,829,770 | | | | | | (4,357,140,737) | | | | | | 3,893,594,973 | | |
NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning of year | | | | | 22,495,428,854 | | | | | | 6,132,599,084 | | | | | | 5,813,639,916 | | | | | | 1,920,044,943 | | |
End of year | | | | $ | 9,336,819,019 | | | | | $ | 22,495,428,854 | | | | | $ | 1,456,499,179 | | | | | $ | 5,813,639,916 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares outstanding, beginning of year | | | | | 187,600,000 | | | | | | 76,300,000 | | | | | | 39,450,000 | | | | | | 19,300,000 | | |
Shares sold | | | | | 268,700,000 | | | | | | 198,750,000 | | | | | | 11,850,000 | | | | | | 41,000,000 | | |
Shares redeemed | | | | | (249,450,000) | | | | | | (87,450,000) | | | | | | (24,600,000) | | | | | | (20,850,000) | | |
Shares outstanding, end of year | | | | | 206,850,000 | | | | | | 187,600,000 | | | | | | 26,700,000 | | | | | | 39,450,000 | | |
| | | ARK Fintech Innovation ETF | | | ARK Space Exploration & Innovation ETF | | ||||||||||||||||||
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2022 | | | March 30, 2021(1) to July 31, 2021 | | ||||||||||||
OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment loss | | | | $ | (13,605,400) | | | | | $ | (15,112,557) | | | | | $ | (815,274) | | | | | $ | (527,856) | | |
Net realized gain (loss) on investments and foreign currency transactions | | | | | (403,587,918) | | | | | | 50,001,871 | | | | | | (8,554,029) | | | | | | (15,013,887) | | |
Net change in unrealized appreciation (depreciation) on investments and foreign currency translations | | | | | (1,364,491,482) | | | | | | (57,496,048) | | | | | | (124,793,118) | | | | | | 4,575,517 | | |
Net decrease in net assets resulting from operations | | | | | (1,781,684,800) | | | | | | (22,606,734) | | | | | | (134,162,421) | | | | | | (10,966,226) | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | — | | | | | | (7,191,728) | | | | | | — | | | | | | — | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | 254,740,340 | | | | | | 4,293,672,073 | | | | | | 5,118,747 | | | | | | 692,463,575 | | |
Cost of shares redeemed | | | | | (1,146,893,053) | | | | | | (1,000,941,520) | | | | | | (158,973,813) | | | | | | (73,944,045) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | (892,152,713) | | | | | | 3,292,730,553 | | | | | | (153,855,066) | | | | | | 618,519,530 | | |
Increase (decrease) in net assets | | | | | (2,673,837,513) | | | | | | 3,262,932,091 | | | | | | (288,017,487) | | | | | | 607,553,304 | | |
NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning of period | | | | | 3,610,269,060 | | | | | | 347,336,969 | | | | | | 607,553,304 | | | | | | — | | |
End of period | | | | $ | 936,431,547 | | | | | $ | 3,610,269,060 | | | | | $ | 319,535,817 | | | | | $ | 607,553,304 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares outstanding, beginning of period | | | | | 71,250,001 | | | | | | 9,600,001 | | | | | | 29,850,001 | | | | | | — | | |
Shares sold | | | | | 9,850,000 | | | | | | 81,600,000 | | | | | | 300,000 | | | | | | 33,500,001 | | |
Shares redeemed | | | | | (28,800,000) | | | | | | (19,950,000) | | | | | | (8,750,000) | | | | | | (3,650,000) | | |
Shares outstanding, end of period | | | | | 52,300,001 | | | | | | 71,250,001 | | | | | | 21,400,001 | | | | | | 29,850,001 | | |
| | | The 3D Printing ETF | | | The ARK Israel Innovative Technology ETF | | ||||||||||||||||||
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | ||||||||||||
OPERATIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income (loss) | | | | $ | (530,350) | | | | | $ | 15,921 | | | | | $ | (294,900) | | | | | $ | 287,036 | | |
Net realized gain (loss) on investments and foreign currency transactions | | | | | (103,341,583) | | | | | | 37,422,039 | | | | | | (56,749,557) | | | | | | (5,519,914) | | |
Net change in unrealized depreciation on investments and foreign currency translations | | | | | (60,510,303) | | | | | | (65,606,758) | | | | | | (18,576,396) | | | | | | (28,479,379) | | |
Net decrease in net assets resulting from operations | | | | | (164,382,236) | | | | | | (28,168,798) | | | | | | (75,620,853) | | | | | | (33,712,257) | | |
DISTRIBUTIONS TO SHAREHOLDERS | | | | | | | | | | | | | | | | | | | | | | | | | |
Distributions from distributable earnings | | | | | (6,527) | | | | | | — | | | | | | (731,187) | | | | | | — | | |
SHAREHOLDER TRANSACTIONS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Proceeds from shares sold | | | | | — | | | | | | 660,321,260 | | | | | | 4,381,509 | | | | | | 347,145,781 | | |
Cost of shares redeemed | | | | | (141,564,471) | | | | | | (157,866,003) | | | | | | (93,611,726) | | | | | | (77,840,654) | | |
Net increase (decrease) in net assets resulting from shareholder transactions | | | | | (141,564,471) | | | | | | 502,455,257 | | | | | | (89,230,217) | | | | | | 269,305,127 | | |
Increase (decrease) in net assets | | | | | (305,953,234) | | | | | | 474,286,459 | | | | | | (165,582,257) | | | | | | 235,592,870 | | |
NET ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | |
Beginning of year | | | | | 515,503,526 | | | | | | 41,217,067 | | | | | | 283,716,346 | | | | | | 48,123,476 | | |
End of year | | | | $ | 209,550,292 | | | | | $ | 515,503,526 | | | | | $ | 118,134,089 | | | | | $ | 283,716,346 | | |
CHANGES IN SHARES OUTSTANDING: | | | | | | | | | | | | | | | | | | | | | | | | | |
Shares outstanding, beginning of year | | | | | 13,550,001 | | | | | | 1,850,001 | | | | | | 9,375,001 | | | | | | 1,925,001 | | |
Shares sold | | | | | — | | | | | | 15,800,000 | | | | | | 200,000 | | | | | | 10,100,000 | | |
Shares redeemed | | | | | (4,500,000) | | | | | | (4,100,000) | | | | | | (3,475,000) | | | | | | (2,650,000) | | |
Shares outstanding, end of year | | | | | 9,050,001 | | | | | | 13,550,001 | | | | | | 6,100,001 | | | | | | 9,375,001 | | |
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | |||||||||||||||
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of year | | | | $ | 84.40 | | | | | $ | 53.70 | | | | | $ | 34.50 | | | | | $ | 29.36 | | | | | $ | 22.24 | | |
Net investment loss(1) | | | | | (0.35) | | | | | | (0.24) | | | | | | (0.28) | | | | | | (0.19) | | | | | | (0.18) | | |
Net realized and unrealized gain (loss) on investments | | | | | (47.00) | | | | | | 31.73 | | | | | | 20.53 | | | | | | 5.80 | | | | | | 7.63 | | |
Total gain (loss) from investment operations | | | | | (47.35) | | | | | | 31.49 | | | | | | 20.25 | | | | | | 5.61 | | | | | | 7.45 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized gains | | | | | (0.38) | | | | | | (0.79) | | | | | | (1.05) | | | | | | (0.47) | | | | | | (0.33) | | |
Total distributions | | | | | (0.38) | | | | | | (0.79) | | | | | | (1.05) | | | | | | (0.47) | | | | | | (0.33) | | |
Net asset value, end of year | | | | $ | 36.67 | | | | | $ | 84.40 | | | | | $ | 53.70 | | | | | $ | 34.50 | | | | | $ | 29.36 | | |
Market value, end of year | | | | $ | 36.61 | | | | | $ | 84.35 | | | | | $ | 53.70 | | | | | $ | 34.58 | | | | | $ | 29.40 | | |
Total Return at Net Asset Value(2) | | | | | (56.27)% | | | | | | 58.48% | | | | | | 60.41% | | | | | | 19.87% | | | | | | 33.80% | | |
Total Return at Market Value(2) | | | | | (56.32)% | | | | | | 58.39% | | | | | | 60.05% | | | | | | 20.00% | | | | | | 33.66% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of year (000’s omitted) | | | | $ | 2,780,026 | | | | | $ | 8,588,014 | | | | | $ | 1,589,856 | | | | | $ | 465,966 | | | | | $ | 232,115 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | |
Net investment loss | | | | | (0.62)% | | | | | | (0.28)% | | | | | | (0.73)% | | | | | | (0.63)% | | | | | | (0.64)% | | |
Portfolio turnover rate(3) | | | | | 51% | | | | | | 45% | | | | | | 50% | | | | | | 64% | | | | | | 80% | | |
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | |||||||||||||||
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of year | | | | $ | 81.12 | | | | | $ | 52.69 | | | | | $ | 33.05 | | | | | $ | 34.93 | | | | | $ | 29.59 | | |
Net investment loss(1) | | | | | (0.30) | | | | | | (0.33) | | | | | | (0.13) | | | | | | (0.13) | | | | | | (0.05) | | |
Net realized and unrealized gain (loss) on investments | | | | | (24.10) | | | | | | 29.42 | | | | | | 19.77 | | | | | | (0.91) | | | | | | 5.89 | | |
Total gain (loss) from investment operations | | | | | (24.40) | | | | | | 29.09 | | | | | | 19.64 | | | | | | (1.04) | | | | | | 5.84 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (0.02) | | |
Net realized gains | | | | | (0.61) | | | | | | (0.66) | | | | | | — | | | | | | (0.84) | | | | | | (0.48) | | |
Total distributions | | | | | (0.61) | | | | | | (0.66) | | | | | | — | | | | | | (0.84) | | | | | | (0.50) | | |
Net asset value, end of year | | | | $ | 56.11 | | | | | $ | 81.12 | | | | | $ | 52.69 | | | | | $ | 33.05 | | | | | $ | 34.93 | | |
Market value, end of year | | | | $ | 56.07 | | | | | $ | 81.18 | | | | | $ | 52.78 | | | | | $ | 33.06 | | | | | $ | 35.01 | | |
Total Return at Net Asset Value(2) | | | | | (30.27)% | | | | | | 55.31% | | | | | | 59.43% | | | | | | (2.66)% | | | | | | 19.86% | | |
Total Return at Market Value(2) | | | | | (30.38)% | | | | | | 55.17% | | | | | | 59.65% | | | | | | (2.84)% | | | | | | 19.98% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of year (000’s omitted) | | | | $ | 1,211,939 | | | | | $ | 2,806,640 | | | | | $ | 447,887 | | | | | $ | 166,897 | | | | | $ | 155,448 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | |
Net investment loss | | | | | (0.42)% | | | | | | (0.41)% | | | | | | (0.34)% | | | | | | (0.39)% | | | | | | (0.15)% | | |
Portfolio turnover rate(3) | | | | | 54% | | | | | | 86% | | | | | | 71% | | | | | | 54% | | | | | | 57% | | |
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | |||||||||||||||
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of year | | | | $ | 119.91 | | | | | $ | 80.37 | | | | | $ | 48.36 | | | | | $ | 44.51 | | | | | $ | 29.59 | | |
Net investment loss(1) | | | | | (0.60) | | | | | | (0.75) | | | | | | (0.38) | | | | | | (0.30) | | | | | | (0.13) | | |
Net realized and unrealized gain (loss) on investments | | | | | (73.39) | | | | | | 42.33 | | | | | | 32.58 | | | | | | 5.32 | | | | | | 15.54(2) | | |
Total gain (loss) from investment operations | | | | | (73.99) | | | | | | 41.58 | | | | | | 32.20 | | | | | | 5.02 | | | | | | 15.41 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (0.09) | | |
Net realized gains | | | | | (0.78) | | | | | | (2.04) | | | | | | (0.19) | | | | | | (1.17) | | | | | | (0.40) | | |
Total distributions | | | | | (0.78) | | | | | | (2.04) | | | | | | (0.19) | | | | | | (1.17) | | | | | | (0.49) | | |
Net asset value, end of year | | | | $ | 45.14 | | | | | $ | 119.91 | | | | | $ | 80.37 | | | | | $ | 48.36 | | | | | $ | 44.51 | | |
Market value, end of year | | | | $ | 45.13 | | | | | $ | 120.00 | | | | | $ | 80.37 | | | | | $ | 48.46 | | | | | $ | 44.55 | | |
Total Return at Net Asset Value(3) | | | | | (62.04)% | | | | | | 51.65% | | | | | | 66.82% | | | | | | 12.14% | | | | | | 52.38%(2) | | |
Total Return at Market Value(3) | | | | | (62.08)% | | | | | | 51.76% | | | | | | 66.47% | | | | | | 12.27% | | | | | | 52.38%(2) | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of year (000’s omitted) | | | | $ | 9,336,819 | | | | | $ | 22,495,429 | | | | | $ | 6,132,599 | | | | | $ | 1,731,253 | | | | | $ | 1,170,588 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | |
Net investment loss | | | | | (0.75)% | | | | | | (0.63)% | | | | | | (0.70)% | | | | | | (0.67)% | | | | | | (0.33)% | | |
Portfolio turnover rate(4) | | | | | 55% | | | | | | 71% | | | | | | 80% | | | | | | 80% | | | | | | 89% | | |
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | |||||||||||||||
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of year | | | | $ | 147.37 | | | | | $ | 99.48 | | | | | $ | 52.32 | | | | | $ | 55.10 | | | | | $ | 36.82 | | |
Net investment loss(1) | | | | | (0.81) | | | | | | (0.98) | | | | | | (0.45) | | | | | | (0.33) | | | | | | (0.09) | | |
Net realized and unrealized gain (loss) on investments | | | | | (88.70) | | | | | | 50.76 | | | | | | 47.61 | | | | | | 3.09 | | | | | | 19.32(2) | | |
Total gain (loss) from investment operations | | | | | (89.51) | | | | | | 49.78 | | | | | | 47.16 | | | | | | 2.76 | | | | | | 19.23 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (0.13) | | |
Net realized gains | | | | | (3.31) | | | | | | (1.89) | | | | | | — | | | | | | (5.54) | | | | | | (0.82) | | |
Total distributions | | | | | (3.31) | | | | | | (1.89) | | | | | | — | | | | | | (5.54) | | | | | | (0.95) | | |
Net asset value, end of year | | | | $ | 54.55 | | | | | $ | 147.37 | | | | | $ | 99.48 | | | | | $ | 52.32 | | | | | $ | 55.10 | | |
Market value, end of year | | | | $ | 54.48 | | | | | $ | 147.55 | | | | | $ | 99.49 | | | | | $ | 52.48 | | | | | $ | 55.08 | | |
Total Return at Net Asset Value(3) | | | | | (61.95)% | | | | | | 50.06% | | | | | | 90.13% | | | | | | 7.49% | | | | | | 52.71%(2) | | |
Total Return at Market Value(3) | | | | | (62.04)% | | | | | | 50.24% | | | | | | 89.58% | | | | | | 7.80% | | | | | | 52.53%(2) | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of year (000’s omitted) | | | | $ | 1,456,499 | | | | | $ | 5,813,640 | | | | | $ | 1,920,045 | | | | | $ | 431,660 | | | | | $ | 672,276 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | |
Net investment loss | | | | | (0.75)% | | | | | | (0.69)% | | | | | | (0.68)% | | | | | | (0.63)% | | | | | | (0.18)% | | |
Portfolio turnover rate(4) | | | | | 76% | | | | | | 120% | | | | | | 93% | | | | | | 92% | | | | | | 68% | | |
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | For the Period February 4, 2019(1) through July 31, 2019 | | ||||||||||||
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 50.67 | | | | | $ | 36.18 | | | | | $ | 22.84 | | | | | $ | 20.00 | | |
Net investment loss(2) | | | | | (0.24) | | | | | | (0.30) | | | | | | (0.10) | | | | | | (0.03) | | |
Net realized and unrealized gain (loss) on investments | | | | | (32.52) | | | | | | 14.97 | | | | | | 13.74 | | | | | | 2.87 | | |
Total gain (loss) from investment operations | | | | | (32.76) | | | | | | 14.67 | | | | | | 13.64 | | | | | | 2.84 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized gains | | | | | — | | | | | | (0.18) | | | | | | (0.30) | | | | | | — | | |
Total distributions | | | | | — | | | | | | (0.18) | | | | | | (0.30) | | | | | | — | | |
Net asset value, end of period | | | | $ | 17.91 | | | | | $ | 50.67 | | | | | $ | 36.18 | | | | | $ | 22.84 | | |
Market value, end of period | | | | $ | 17.88 | | | | | $ | 50.68 | | | | | $ | 36.26 | | | | | $ | 22.86 | | |
Total Return at Net Asset Value(3) | | | | | (64.66)% | | | | | | 40.58% | | | | | | 60.36% | | | | | | 14.21% | | |
Total Return at Market Value(3) | | | | | (64.72)% | | | | | | 40.29% | | | | | | 60.59% | | | | | | 14.30% | | |
Ratios/Supplemental Data: | | | | | | | | | | | �� | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 936,432 | | | | | $ | 3,610,269 | | | | | $ | 347,337 | | | | | $ | 74,233 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75% | | | | | | 0.75%(4) | | |
Net investment loss | | | | | (0.65)% | | | | | | (0.60)% | | | | | | (0.40)% | | | | | | (0.24)%(4) | | |
Portfolio turnover rate(5) | | | | | 75% | | | | | | 78% | | | | | | 55% | | | | | | 22% | | |
| | | Year Ended July 31, 2022 | | | For the Period March 30, 2021(1) through July 31, 2021 | | ||||||
Per Share Data: | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 20.35 | | | | | $ | 20.00 | | |
Net investment loss(2) | | | | | (0.03) | | | | | | (0.02) | | |
Net realized and unrealized gain (loss) on investments | | | | | (5.39) | | | | | | 0.37 | | |
Total gain (loss) from investment operations | | | | | (5.42) | | | | | | 0.35 | | |
Total distributions | | | | | — | | | | | | — | | |
Net asset value, end of period | | | | $ | 14.93 | | | | | $ | 20.35 | | |
Market value, end of period | | | | $ | 14.93 | | | | | $ | 20.34 | | |
Total Return at Net Asset Value(3) | | | | | (26.64)% | | | | | | 1.77% | | |
Total Return at Market Value(3) | | | | | (26.60)% | | | | | | 1.70% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 319,536 | | | | | $ | 607,553 | | |
Ratio to average net assets of: | | | | | | | | | | | | | |
Expenses, prior to expense waivers and reimbursements | | | | | 0.75% | | | | | | 0.75%(4) | | |
Expenses, net of expense waivers and reimbursements | | | | | 0.70% | | | | | | 0.71%(4) | | |
Net investment loss | | | | | (0.18)% | | | | | | (0.26)%(4) | | |
Portfolio turnover rate(5) | | | | | 41% | | | | | | 46% | | |
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | Year Ended July 31, 2018 | | |||||||||||||||
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of year | | | | $ | 38.04 | | | | | $ | 22.28 | | | | | $ | 22.04 | | | | | $ | 24.22 | | | | | $ | 25.52 | | |
Net investment loss(1) | | | | | (0.05) | | | | | | 0.00(2) | | | | | | (0.00)(2) | | | | | | (0.01) | | | | | | (0.04) | | |
Net realized and unrealized gain (loss) on investments | | | | | (14.84) | | | | | | 15.76 | | | | | | 0.25 | | | | | | (2.01) | | | | | | (0.73) | | |
Total gain (loss) from investment operations | | | | | (14.89) | | | | | | 15.76 | | | | | | 0.25 | | | | | | (2.02) | | | | | | (0.77) | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | (0.00)(2) | | | | | | — | | | | | | (0.01) | | | | | | — | | | | | | — | | |
Net realized gains | | | | | — | | | | | | — | | | | | | — | | | | | | (0.16) | | | | | | (0.53) | | |
Total distributions | | | | | (0.00) | | | | | | — | | | | | | (0.01) | | | | | | (0.16) | | | | | | (0.53) | | |
Net asset value, end of year | | | | $ | 23.15 | | | | | $ | 38.04 | | | | | $ | 22.28 | | | | | $ | 22.04 | | | | | $ | 24.22 | | |
Market value, end of year | | | | $ | 23.16 | | | | | $ | 38.00 | | | | | $ | 22.16 | | | | | $ | 22.25 | | | | | $ | 24.32 | | |
Total Return at Net Asset Value(3) | | | | | (39.14)% | | | | | | 70.76% | | | | | | 1.15% | | | | | | (8.25)% | | | | | | (3.05)% | | |
Total Return at Market Value(3) | | | | | (39.05)% | | | | | | 71.48% | | | | | | (0.34)% | | | | | | (7.76)% | | | | | | (2.64)% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of year (000’s omitted) | | | | $ | 209,550 | | | | | $ | 515,504 | | | | | $ | 41,217 | | | | | $ | 39,672 | | | | | $ | 47,220 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66% | | | | | | 0.66% | | |
Net investment loss | | | | | (0.15)% | | | | | | 0.00%(4) | | | | | | 0.00%(4) | | | | | | (0.04)% | | | | | | (0.17)% | | |
Portfolio turnover rate(5) | | | | | 37% | | | | | | 59% | | | | | | 37% | | | | | | 51% | | | | | | 53% | | |
| | | Year Ended July 31, 2022 | | | Year Ended July 31, 2021 | | | Year Ended July 31, 2020 | | | Year Ended July 31, 2019 | | | For the Period December 5, 2017(1) through July 31, 2018 | | |||||||||||||||
Per Share Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net asset value, beginning of period | | | | $ | 30.26 | | | | | $ | 25.00 | | | | | $ | 20.54 | | | | | $ | 20.85 | | | | | $ | 20.00 | | |
Net investment income (loss)(2) | | | | | (0.04) | | | | | | 0.05 | | | | | | (0.03) | | | | | | 0.08 | | | | | | (0.00)(3) | | |
Net realized and unrealized gain (loss) on investments | | | | | (10.75) | | | | | | 5.21 | | | | | | 4.97 | | | | | | 0.18 | | | | | | 0.85 | | |
Total gain (loss) from investment operations | | | | | (10.79) | | | | | | 5.26 | | | | | | 4.94 | | | | | | 0.26 | | | | | | 0.85 | | |
Distributions to shareholders: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net investment income | | | | | (0.10) | | | | | | — | | | | | | (0.48) | | | | | | (0.57) | | | | | | — | | |
Total distributions | | | | | (0.10) | | | | | | — | | | | | | (0.48) | | | | | | (0.57) | | | | | | — | | |
Net asset value, end of period | | | | $ | 19.37 | | | | | $ | 30.26 | | | | | $ | 25.00 | | | | | $ | 20.54 | | | | | $ | 20.85 | | |
Market value, end of period | | | | $ | 19.36 | | | | | $ | 30.15 | | | | | $ | 24.74 | | | | | $ | 20.64 | | | | | $ | 21.04 | | |
Total Return at Net Asset Value(4) | | | | | (35.79)% | | | | | | 21.06% | | | | | | 24.31% | | | | | | 1.57% | | | | | | 4.27% | | |
Total Return at Market Value(4) | | | | | (35.57)% | | | | | | 21.87% | | | | | | 22.41% | | | | | | 1.20% | | | | | | 5.20% | | |
Ratios/Supplemental Data: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net assets, end of period (000’s omitted) | | | | $ | 118,134 | | | | | $ | 283,716 | | | | | $ | 48,123 | | | | | $ | 19,512 | | | | | $ | 21,896 | | |
Ratio to average net assets of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expenses | | | | | 0.49% | | | | | | 0.49% | | | | | | 0.49% | | | | | | 0.49% | | | | | | 0.49%(5) | | |
Net investment income (loss) | | | | | (0.15)% | | | | | | 0.15% | | | | | | (0.14)% | | | | | | 0.37% | | | | | | (0.03)%(5) | | |
Portfolio turnover rate(6) | | | | | 58% | | | | | | 88% | | | | | | 86% | | | | | | 57% | | | | | | 40% | | |
Fund | | | Purchases | | | Sales | | ||||||
ARK Genomic Revolution ETF | | | | $ | 2,486,135,657 | | | | | $ | 2,485,900,438 | | |
ARK Autonomous Technology & Robotics ETF | | | | | 1,070,823,703 | | | | | | 1,040,309,936 | | |
ARK Innovation ETF | | | | | 8,332,286,798 | | | | | | 8,197,924,262 | | |
ARK Next Generation Internet ETF | | | | | 2,596,189,851 | | | | | | 2,717,484,250 | | |
ARK Fintech Innovation ETF | | | | | 1,591,986,899 | | | | | | 1,603,145,338 | | |
ARK Space Exploration & Innovation ETF | | | | | 182,535,187 | | | | | | 191,346,282 | | |
The 3D Printing ETF | | | | | 130,028,347 | | | | | | 135,467,143 | | |
The ARK Israel Innovative Technology ETF | | | | | 112,959,571 | | | | | | 118,743,341 | | |
| | | In-Kind | | |||||||||
Fund | | | Subscriptions | | | Redemptions | | ||||||
ARK Genomic Revolution ETF | | | | $ | 2,481,719,510 | | | | | $ | 4,136,940,630 | | |
ARK Autonomous Technology & Robotics ETF | | | | | 32,817,941 | | | | | | 964,009,230 | | |
ARK Innovation ETF | | | | | 17,700,507,147 | | | | | | 18,167,037,086 | | |
ARK Next Generation Internet ETF | | | | | 1,083,960,167 | | | | | | 2,608,546,796 | | |
ARK Fintech Innovation ETF | | | | | 245,457,604 | | | | | | 1,136,425,900 | | |
ARK Space Exploration & Innovation ETF | | | | | 4,331,610 | | | | | | 148,780,074 | | |
The 3D Printing ETF | | | | | — | | | | | | 136,597,367 | | |
The ARK Israel Innovative Technology ETF | | | | | 4,350,524 | | | | | | 87,968,363 | | |
follows:
Fund | | | Cost | | | Gross Unrealized Appreciation | | | Gross Unrealized Depreciation | | | Net Unrealized Appreciation (Depreciation) | | ||||||||||||
ARK Genomic Revolution ETF | | | | $ | 7,124,859,398 | | | | | $ | 22,754,308 | | | | | $ | (4,363,980,837) | | | | | $ | (4,341,226,529) | | |
ARK Autonomous Technology & Robotics ETF | | | | | 1,949,785,642 | | | | | | 76,227,294 | | | | | | (813,676,791) | | | | | | (737,449,497) | | |
ARK Innovation ETF | | | | | 21,904,169,165 | | | | | | 112,009,979 | | | | | | (12,676,370,218) | | | | | | (12,564,360,239) | | |
ARK Next Generation Internet ETF | | | | | 3,850,218,530 | | | | | | 43,186,923 | | | | | | (2,436,003,529) | | | | | | (2,392,816,606) | | |
ARK Fintech Innovation ETF | | | | | 2,311,308,820 | | | | | | 9,055,893 | | | | | | (1,381,906,658) | | | | | | (1,372,850,765) | | |
ARK Space Exploration & Innovation ETF | | | | | 446,389,764 | | | | | | 5,047,101 | | | | | | (131,847,957) | | | | | | (126,800,856) | | |
The 3D Printing ETF | | | | | 333,848,436 | | | | | | 2,708,935 | | | | | | (127,024,055) | | | | | | (124,315,120) | | |
The ARK Israel Innovative Technology ETF | | | | | 161,897,822 | | | | | | 6,209,639 | | | | | | (50,582,132) | | | | | | (44,372,493) | | |
Fund | | | Undistributed Income | | | Undistributed Long-term Capital Gains | | | Accumulated Capital Gains/(Losses) | | | Net Unrealized Appreciation (Depreciation) | | | Total Earnings (Losses) | | |||||||||||||||
ARK Genomic Revolution ETF | | | | $ | — | | | | | $ | — | | | | | $ | (476,759,498) | | | | | $ | (4,341,226,529) | | | | | $ | (4,817,986,027) | | |
ARK Autonomous Technology & Robotics ETF | | | | | (32,091,568) | | | | | | — | | | | | | — | | | | | | (737,449,497) | | | | | | (769,541,065) | | |
ARK Innovation ETF | | | | | — | | | | | | — | | | | | | (1,487,260,103) | | | | | | (12,564,360,239) | | | | | | (14,051,620,342) | | |
ARK Next Generation Internet ETF | | | | | (426,218,134) | | | | | | — | | | | | | — | | | | | | (2,392,816,606) | | | | | | (2,819,034,740) | | |
ARK Fintech Innovation ETF | | | | | — | | | | | | — | | | | | | (690,049,837) | | | | | | (1,372,876,525) | | | | | | (2,062,926,362) | | |
ARK Space Exploration & Innovation ETF | | | | | — | | | | | | — | | | | | | (21,709,676) | | | | | | (126,813,527) | | | | | | (148,523,203) | | |
The 3D Printing ETF | | | | | — | | | | | | — | | | | | | (113,077,053) | | | | | | (124,327,861) | | | | | | (237,404,914) | | |
The ARK Israel Innovative Technology ETF | | | | | (900,158) | | | | | | — | | | | | | (78,844,112) | | | | | | (44,372,608) | | | | | | (124,116,878) | | |
Fund | | | Accumulated Earnings | | | Paid-in Capital | | ||||||
ARK Genomic Revolution ETF | | | | $ | 34,926,455 | | | | | $ | (34,926,455) | | |
ARK Autonomous Technology & Robotics ETF | | | | | (78,040,733) | | | | | | 78,040,733 | | |
ARK Innovation ETF | | | | | (1,755,435,406) | | | | | | 1,755,435,406 | | |
ARK Next Generation Internet ETF | | | | | (230,455,091) | | | | | | 230,455,091 | | |
ARK Fintech Innovation ETF | | | | | (52,834,075) | | | | | | 52,834,075 | | |
ARK Space Exploration & Innovation ETF | | | | | (2,103,798) | | | | | | 2,103,798 | | |
The 3D Printing ETF | | | | | 8,541,798 | | | | | | (8,541,798) | | |
The ARK Israel Innovative Technology ETF | | | | | (3,182,486) | | | | | | 3,182,486 | | |
| | | Period Ended July 31, 2022 | | | Period Ended July 31, 2021 | | ||||||||||||||||||
Fund | | | Ordinary Income* | | | Long-Term Capital Gain | | | Ordinary Income* | | | Long-Term Capital Gain | | ||||||||||||
ARK Genomic Revolution ETF | | | | $ | 32,103,552 | | | | | $ | — | | | | | $ | 39,550,514 | | | | | $ | 22,834,200 | | |
ARK Autonomous Technology & Robotics ETF | | | | | 8,785,214 | | | | | | 8,442,535 | | | | | | 6,569,669 | | | | | | 7,864,531 | | |
ARK Innovation ETF | | | | | 87,374,812 | | | | | | 46,601,172 | | | | | | 231,952,950 | | | | | | 59,361,225 | | |
ARK Next Generation Internet ETF | | | | | 6,287,889 | | | | | | 99,936,387 | | | | | | 68,580,176 | | | | | | — | | |
ARK Fintech Innovation ETF | | | | | — | | | | | | — | | | | | | 7,119,392 | | | | | | 72,336 | | |
ARK Space Exploration & Innovation ETF | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
The 3D Printing ETF | | | | | 6,527 | | | | | | — | | | | | | — | | | | | | — | | |
The ARK Israel Innovative Technology ETF | | | | | 731,187 | | | | | | — | | | | | | — | | | | | | — | | |
Fund | | | Late Year Ordinary Deferral | | | Capital Post-October Loss | | ||||||
ARK Autonomous Technology & Robotics ETF | | | | $ | — | | | | | $ | (32,091,568) | | |
ARK Next Generation Internet ETF | | | | | (8,978,617) | | | | | | (417,239,517) | | |
The ARK Israel Innovative Technology ETF | | | | | (900,158) | | | | | | — | | |
| | | Short-Term | | | Long-Term | | | Total Amount | | |||||||||
ARK Genomic Revolution ETF | | | | $ | 239,669,771 | | | | | $ | 237,089,727 | | | | | $ | 476,759,498 | | |
ARK Autonomous Technology & Robotics ETF | | | | | — | | | | | | — | | | | | | — | | |
ARK Innovation ETF | | | | | 948,020,853 | | | | | | 539,239,250 | | | | | | 1,487,260,103 | | |
ARK Next Generation Internet ETF | | | | | — | | | | | | — | | | | | | — | | |
ARK Fintech Innovation ETF | | | | | 541,948,870 | | | | | | 148,100,967 | | | | | | 690,049,837 | | |
ARK Space Exploration & Innovation ETF | | | | | 16,436,434 | | | | | | 5,273,242 | | | | | | 21,709,676 | | |
The 3D Printing ETF | | | | | 86,427,247 | | | | | | 26,649,806 | | | | | | 113,077,053 | | |
The ARK Israel Innovative Technology ETF | | | | | 52,369,545 | | | | | | 26,474,567 | | | | | | 78,844,112 | | |
Funds comprising the ARK ETF Trust | | | Statement of changes in net assets | | | Financial highlights | |
ARK Genomic Revolution ETF ARK Autonomous Technology & Robotics ETF ARK Innovation ETF ARK Next Generation Internet ETF The 3D Printing ETF | | | For the year ended July 31, 2021 | | | For each of the four years in the period ended July 31, 2021 | |
ARK Fintech Innovation ETF | | | For the year ended July 31, 2021 | | | For each of the two years in the period ended July 31, 2021 and for the period from February 4, 2019 (commencement of operations) through July 31, 2019 | |
ARK Space Exploration & Innovation ETF | | | For the period from March 30, 2021 (commencement of operations) to July 31, 2021 | | | For the period from March 30, 2021 (commencement of operations) through July 31, 2021 | |
ARK Israel Innovative Technology ETF | | | For the year ended July 31, 2021 | | | For each of the three years in the period ended July 31, 2021 and for the period from December 5, 2017 (commencement of operations) through July 31, 2018 | |
September 27, 2022
| | | Qualified Dividend Income* | | | Dividends Received Deduction* | | ||||||
ARK Genomic Revolution ETF | | | | | 24% | | | | | | 5% | | |
ARK Autonomous Technology & Robotics ETF | | | | | 48% | | | | | | 34% | | |
ARK Innovation ETF | | | | | 5% | | | | | | 2% | | |
ARK Next Generation Internet ETF | | | | | 4% | | | | | | 1% | | |
ARK Fintech Innovation ETF | | | | | 0% | | | | | | 0% | | |
ARK Space Exploration & Innovation ETF | | | | | 0% | | | | | | 0% | | |
The 3D Printing ETF | | | | | 0% | | | | | | 0% | | |
The ARK Israel Innovative Technology ETF | | | | | 1% | | | | | | 0% | | |
Name, Address(1) and Age | | | Position(s) Held with the Trust | | | Term of Office(2) and Length of Time Served | | | Principal Occupation(s) During Past Five Years | | | Other Directorships Held By Trustee During Past Five Years | |
Scott R. Chichester, 52 | | | Trustee | | | Since June 30, 2014 | | | Chief Financial Officer, Sterling Consolidated Corp (since 2011); Director and Founder, DirectPay USA LLC (since 2006) (payroll company); Founder, Madison Park Advisors LLC (since 2011) (public company advisory); Proprietor, Scott R. Chichester CPA (since 2001) (CPA firm). | | | Trustee and audit committee chairman of Global X ETF fund complex (2008 – 2018); Director of Sterling Consolidated Corp (since 2011). | |
Darlene T. DeRemer, 66 | | | Trustee | | | Since June 30, 2014 | | | Managing Partner, Grail Partners LLC (2005 – 2019). | | | Trustee, Member of Investment and Endowment Committee of Syracuse University (since 2010); Interested Trustee, American Independence Funds (2015 – 2019); Trustee, Risk X Investment Funds (2016 – 2020); Director, United Capital Financial Planners (2008 – 2019); Director, Hillcrest Asset Management (since 2007); Board Member, Confluence Technologies LLC (2018 – 2021). | |
Robert G. Zack, 74 | | | Trustee | | | Since June 30, 2014 | | | Adjunct Professor at the University of Virginia School of Law (since 2014); Counsel, Dechert LLP (2012 – 2014); Executive Vice President, OppenheimerFunds, Inc. (2004 – 2011); General Counsel, OppenheimerFunds, Inc. (2002 – 2010); Secretary and General Counsel, Oppenheimer Acquisition Corp. (2001 – 2011); Executive Vice President, General Counsel and Director, OFI Trust Co. (2001 – 2011); Vice President and Secretary, Oppenheimer Funds (2002 – 2011). | | | Trustee of University of Virginia Law School Foundation 2011 – 2022. | |
Name, Address(1) and Age | | | Position(s) Held with the Trust | | | Term of Office(2) and Length of Time Served | | | Principal Occupation(s) During Past Five Years | | | Other Directorships Held By Trustee During Past Five Years | |
Catherine D. Wood, 66 | | | Chief Executive Officer, Chief Investment Officer and Trustee | | | Since June 7, 2013 | | | Managing Member, Founder and Chief Executive Officer, ARK Investment Management LLC (since 2013); President, ARK ETF Trust (2014 – 2015); Senior Vice President and Chief Investment Officer of Thematic Portfolios, AllianceBernstein L.P. (2009 – 2013). | | | Executive Director, Wall Street Blockchain Alliance (since 2018); Independent Non-Executive Director, Amun Holdings Ltd (since 2018); Director, NexPoint Advisors: NexPoint Residential Trust Inc., NexPoint Real Estate Finance Inc. and VineBrook Homes Trust Inc. (since 2020); Director, MIMIK Technologies Inc. (since 2021); Board Member, Strange Brewing SA (since 2018). | |
Officer’s Name, Address(1) and Age | | | Position(s) Held with the Trust | | | Term of Office(2) and Length of Time Served | | | Principal Occupation(s) During The Past Five Years | |
Catherine D. Wood, 66 | | | Trustee, Chief Executive Officer and Chief Investment Officer | | | Since 6/30/14 | | | Managing Member, Founder and Chief Executive Officer, ARK Investment Management LLC (since 2013); President, ARK ETF Trust (2014 – 2015). | |
William C. Cox, 56 | | | Treasurer and Chief Financial Officer | | | Since 6/30/14 | | | Principal Financial Officer, Investment Products, ARK Investment Management LLC (since June 2018); Fund Principal Financial Officer, Foreside Financial Group, LLC (2013 – 2018). | |
Kellen Carter, 39 | | | Chief Compliance Officer; Secretary; Chief Legal Officer | | | Since 5/26/16 Since 5/26/16 Since 12/16/16 | | | Chief Compliance Officer, Associate General Counsel (since April 2016), Interim General Counsel, ARK Investment Management LLC (2016 – 2018), Corporate Counsel, ARK Investment Management LLC (since July 2018); Management Consultant, Wealth and Asset Management Division Ernst & Young LLP (2014 – 2016). | |
Forest Wolfe, 49 | | | Chief Legal Officer | | | Since 12/16/22 | | | General Counsel, ARK Investment Management LLC (since August 2021); General Counsel, Angelo, Gordon & Co., L.P. (2012 – 2021). | |
Thomas G. Staudt, 34 | | | President Vice President | | | Since 12/16/16 03/27/15 – 12/16/16 | | | Director of Product Development and Associate Operating Officer (2015 – 2016), Interim Chief Operating Officer, ARK Investment Management LLC (2016 – 2018), Chief Operating Officer, ARK Investment Management LLC (since April 2018); Associate Portfolio Manager, ARK Investment Management LLC (2014 – 2015). | |
ARK Investment Management LLC
200 Central Avenue, Suite 1850
St. Petersburg, FL 33701
The Bank of New York Mellon
240 Greenwich Street
New York, NY 10286
Foreside Fund Services, LLC
Three Canal Plaza, Suite 100
Portland, ME 04101
Ernst & Young LLP
One Manhattan West
New York, NY 10001
(b) | Not applicable. |
Item 2. Code of Ethics.
(a) | As of the end of the period covered by this report, the registrant has adopted a code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party (“Code of Ethics”). |
(b) | For purposes of this Item, the term “code of ethics” means written standards that are reasonably designed to deter wrongdoing and to promote: |
(1) | Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; |
(2) | Full, fair, accurate, timely, and understandable disclosure in reports and documents that a registrant files with, or submits to, the Commission and in other public communications made by the registrant; |
(3) | Compliance with applicable governmental laws, rules, and regulations; |
(4) | The prompt internal reporting of violations of the code to an appropriate person or persons identified in the code; and |
(5) | Accountability for adherence to the code. |
(c) | There have been no amendments, during the period covered by this report, to a provision of the code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party, and that relates to any element of the code of ethics description enumerated in paragraph (b) of this item. |
(d) | During the period covered by this report, the registrant did not grant any waivers, including an implicit waiver, from a provision of the Code of Ethics that relates to one or more of the items set forth in paragraph (b) of this Item’s instructions. |
(e) | The registrant does not intend to satisfy the disclosure requirements under paragraph (c) or (d) of this Item regarding an amendment to, or a waiver from, a provision of its code of ethics and that relates to any element of the code of ethics definition enumerated in paragraph (b) of this Item by posting such information on its Internet website. |
(f) | The Code of Ethics is attached hereto as Exhibit 13(a)(1). |
Item 3. Audit Committee Financial Expert.
The registrant’s board of trustees has determined that the registrant has at least one “audit committee financial expert” (as defined in Item 3 of Form N-CSR) serving on its audit committee. Scott R. Chichester is qualified to serve as an “audit committee financial expert” and is “independent” (as each term is defined in Item 3 of Form N-CSR).
Item 4. Principal Accountant Fees and Services.
Below are the amount of fees that Ernst & Young LLP (“EY”), the Trust’s current Independent Registered Public Accounting Firm, billed to the Trust during the Trust’s fiscal year ended July 31, 2022 and the amount of fees that Tait Weller (“TW”), the Trust’s prior Independent Registered Public Accounting Firm, billed to the Trust during the Trust’s fiscal year ended July 31, 2021.
Audit Fees
(a) | The aggregate fees billed for each of the last two fiscal years for professional services rendered by EY and TW, the principal accountant for each respective audit of the registrant's annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for the fiscal years were $120,000 for July 31, 2022 and $122,000 for July 31, 2021. |
Audit-Related Fees
(b) | The aggregate fees billed in each of the last two fiscal years for assurance and related services by EY and TW that are reasonably related to the performance of each respective audit of the registrant's financial statements and are not reported under paragraph (a) of this Item are $0 for July 31, 2022 and $0 for July 31, 2021. |
Tax Fees
(c) | The aggregate fees billed in each of the last two fiscal years for professional services rendered by EY and TW for tax compliance, tax advice, and tax planning were $75,650 for July 31, 2022 and $39,500 for July 31, 2021. Such services included review of excise distribution calculations (if applicable), preparation of the Funds’ federal, state and excise tax returns, tax services related to mergers and routine consulting. |
All Other Fees
(d) | The aggregate fees billed in each of the last two fiscal years for products and services provided by EY and TW, other than the services reported in paragraphs (a) through (c) of this Item are $0 for July 31, 2022 and $0 for July 31, 2021. |
(e)(1) | The registrant’s audit committee (“Audit Committee”) has adopted an Audit and Non-Audit Services Pre-Approval Policy (“Pre-Approval Policy”) that applies to any and all engagements of the independent auditor to the registrant for audit, non-audit, tax or other services. Pursuant to the Pre-Approval Policy, the Audit Committee is required to pre-approve the audit services and permissible non-audit services proposed to be performed by the independent auditor for the registrant to assure that the independence of the auditor is not in any way compromised or impaired. In assessing whether a particular audit or non-audit service should be approved, the Audit Committee will take into account the ratio between the total amounts paid for audit, audit-related, tax and other services, based on historical patterns, with a view toward assuring that the level of fees paid for non-audit services as they relate to the fees paid for audit services does not compromise or impair the independence of the auditor. The Audit Committee may either grant general pre-approval of proposed services of the independent auditor through adoption of a list of authorized services together with a budget of expected costs for those services (“general pre-approval”), or specific pre-approval of services provided on a case-by-case basis (“specific pre-approval”). Unless particular services have received general pre-approval, those services will require specific pre-approval by the Audit Committee before any such services can be provided by the independent auditor. The annual audit services engagement terms and fees for the independent auditor for the registrant require specific pre-approval of the Audit Committee. The Audit Committee may grant general pre-approval for (i) other audit services, which are those services that only the independent auditor reasonably can provide, (ii) audit related services, (iii) those tax services that have historically been provided by the independent auditor, and (iv) those permissible non-audit services classified as “all other” services that the Audit Committee believes are routine and recurring services. The Audit Committee from time to time may delegate either general or specific pre-approval authority to one or more of its members. Any member to whom such authority is delegated must report, for informational purposes only, any pre-approval decisions to the Audit Committee at its next scheduled meeting. The Audit Committee has not delegated either general or specific pre-approval authority to one or more of its members. |
(e)(2) | The percentage of services described in each of paragraphs (b) through (d) of this Item that were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X are as follows: |
(b) N/A
(c) 100%
(d) N/A
(f) | The percentage of hours expended on the principal accountant's engagement to audit the registrant's financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant's full-time, permanent employees was less than fifty percent. |
(g) | The aggregate non-audit fees billed by the registrant's accountant for services rendered to the registrant, and rendered to the registrant's investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant for the registrant’s fiscal year ended July 31, 2021 were $39,500 and for July 31, 2022 were $205,871. |
(h) | The registrant's audit committee of the board of trustees has considered whether the provision of non-audit services that were rendered to the registrant's investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant's independence. |
(i) | Not applicable. |
(j) | Not applicable. |
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) | The Schedule of Investments in securities of unaffiliated issuers as of the close of the reporting period is included as part of the report to shareholders filed under Item 1(a) of this form. |
(b) | Not applicable. |
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant’s board of trustees, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.
Item 11. Controls and Procedures.
(a) | As of a date within 90 days of the filing date of this Form N-CSR, the registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”) (17 CFR 270.30a-3(c))) are effective, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)). |
(b) | There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d)) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting. |
Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 13. Exhibits.
(a)(1) | Code of ethics, or any amendment thereto, that is the subject of disclosure required by Item 2 is attached hereto. |
(a)(2) | Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto. |
(a)(2)(1) | Not applicable. |
(a)(2)(2) | Change in the registrant’s independent public accountant is attached hereto. |
Tait, Weller & Baker LLP (TW) served as the independent registered public accounting firm for the Funds of the ARK ETF Trust (comprising of ARK Genomic Revolution ETF; ARK Autonomous Technology & Robotics ETF; ARK Innovation ETF; ARK Next Generation Internet ETF; The 3D Printing ETF; ARK Israel Innovative Technology ETF; ARK Fintech Innovation ETF; and ARK Space Exploration & Innovation ETF (each a "Fund" and, collectively, the "Funds")) for the fiscal years ended July 31, 2020 and July 31, 2021. TW’s reports on the financial statements for the fiscal years ended July 31, 2020 and July 31, 2021 contained no adverse opinion or disclaimer of opinion nor were they qualified or modified as to uncertainty, audit scope or accounting principle. Through June 27, 2022, the date of dismissal, and during such fiscal year-ends, (i) there were no disagreements with TW on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which agreements, if not resolved to the satisfaction of TW, would have caused them to make reference to the subject matter of the disagreements in connection with their reports on the Funds’ financial statements for period, and (ii) there were no “reportable events” of the kind described in Item 304(a)(1)(v) of Regulation S-K under the Securities Exchange Act of 1934, as amended.
On June 27, 2022, the Audit Committee and the Trust’s Board of Trustees approved the engagement of Ernst & Young LLP (EY) to serve as the independent registered public accounting firm for the Funds’ fiscal year ending July 31, 2022, thereby replacing TW effective upon completion of their July 31, 2021 audits and issuance of their reports thereon. Through June 27, 2022 and during the Funds’ fiscal years ended July 31, 2020 and July 31, 2021, neither the Trust nor the Funds’, nor anyone in their behalf, consulted with EY on items which: (1) concerned the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Funds’ financial statements; or (ii) concerned the subject of a disagreement (as defined in paragraph (a)(1)(iv) of Item 304 of Regulation S-K) or reportable events (as described in paragraph (a)(1)(v) of said Item 304).
The Funds have requested that TW furnish it with a letter addressed to the U.S. Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of such letter is filed as an Exhibit to this Form N-CSR.
(b) | Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) | ARK ETF Trust | |
By (Signature and Title)* | /s/ Catherine D. Wood | |
Catherine D. Wood | ||
Chief Executive Officer and Chief Investment Officer | ||
(principal executive officer) |
Date | 10/7/2022 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By (Signature and Title)* | /s/ Catherine D. Wood | |
Catherine D. Wood | ||
Chief Executive Officer and Chief Investment Officer | ||
(principal executive officer) |
Date | 10/7/2022 |
By (Signature and Title)* | /s/ William C. Cox | |
William C. Cox | ||
Treasurer and Chief Financial Officer | ||
(principal financial officer) |
Date | 10/7/2022 |
* Print the name and title of each signing officer under his or her signature.